<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Interventions for recurrent corneal erosions - Watson, SL - 2018 | Cochrane Library</title> <meta content="Interventions for recurrent corneal erosions - Watson, SL - 2018 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001861.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Interventions for recurrent corneal erosions - Watson, SL - 2018 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001861.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD001861.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Interventions for recurrent corneal erosions" name="citation_title"/> <meta content="Stephanie L Watson" name="citation_author"/> <meta content="Save Sight Institute" name="citation_author_institution"/> <meta content="stephanie.watson@sydney.edu.au" name="citation_author_email"/> <meta content="Vannessa Leung" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="7" name="citation_issue"/> <meta content="10.1002/14651858.CD001861.pub4" name="citation_doi"/> <meta content="2018" name="citation_date"/> <meta content="2018/07/09" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001861.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001861.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001861.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Corneal Injuries; Anti‐Bacterial Agents [therapeutic use]; Contact Lenses; Corneal Diseases [*prevention &amp; control, therapy]; Debridement [methods]; Eye Infections [etiology, *prevention &amp; control]; Glucocorticoids [therapeutic use]; Keratectomy [adverse effects, methods]; Lubricant Eye Drops [administration &amp; dosage]; Pain Measurement; Prednisolone [therapeutic use]; Randomized Controlled Trials as Topic; Recurrence; Secondary Prevention; Tetracycline [therapeutic use]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001861.pub4&amp;doi=10.1002/14651858.CD001861.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001861.pub4&amp;doi=10.1002/14651858.CD001861.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001861.pub4&amp;doi=10.1002/14651858.CD001861.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001861.pub4&amp;doi=10.1002/14651858.CD001861.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001861.pub4&amp;doi=10.1002/14651858.CD001861.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001861.pub4&amp;doi=10.1002/14651858.CD001861.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001861.pub4&amp;doi=10.1002/14651858.CD001861.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001861.pub4&amp;doi=10.1002/14651858.CD001861.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001861.pub4&amp;doi=10.1002/14651858.CD001861.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001861.pub4&amp;doi=10.1002/14651858.CD001861.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001861.pub4&amp;doi=10.1002/14651858.CD001861.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001861.pub4&amp;doi=10.1002/14651858.CD001861.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001861.pub4&amp;doi=10.1002/14651858.CD001861.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001861.pub4&amp;doi=10.1002/14651858.CD001861.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001861.pub4&amp;doi=10.1002/14651858.CD001861.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001861.pub4&amp;doi=10.1002/14651858.CD001861.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001861.pub4&amp;doi=10.1002/14651858.CD001861.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001861.pub4&amp;doi=10.1002/14651858.CD001861.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001861.pub4&amp;doi=10.1002/14651858.CD001861.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001861.pub4&amp;doi=10.1002/14651858.CD001861.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001861.pub4&amp;doi=10.1002/14651858.CD001861.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001861.pub4&amp;doi=10.1002/14651858.CD001861.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001861.pub4&amp;doi=10.1002/14651858.CD001861.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="k5rEBE5b";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD001861\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD001861\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001861\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001861\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","ms","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD001861.pub4",title:"Interventions for recurrent corneal erosions",firstPublishedDate:"Jul 9, 2018 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Eyes and Vision Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=k5rEBE5b&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001861.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD001861.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD001861.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD001861.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001861.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD001861.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD001861.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD001861.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD001861.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD001861.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>5419 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD001861.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001861.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001861.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001861.pub4/full#CD001861-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001861.pub4/full#CD001861-sec-0146"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001861.pub4/full#CD001861-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001861.pub4/full#CD001861-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001861.pub4/full#CD001861-sec-0028"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001861.pub4/full#CD001861-sec-0029"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001861.pub4/full#CD001861-sec-0044"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001861.pub4/full#CD001861-sec-0140"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001861.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001861.pub4/appendices#CD001861-sec-0151"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001861.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001861.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/table_n/CD001861StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/table_n/CD001861StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001861.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001861.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001861.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD001861.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD001861.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD001861.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2018 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Interventions for recurrent corneal erosions</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001861.pub4/information#CD001861-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Stephanie L Watson</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001861.pub4/information#CD001861-cr-0003">Vannessa Leung</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/information/en#CD001861-sec-0167">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 09 July 2018 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD001861.pub4">https://doi.org/10.1002/14651858.CD001861.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD001861-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001861-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD001861-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD001861-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD001861-abs-0009">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD001861-abs-0001" lang="en"> <section id="CD001861-sec-0001"> <h3 class="title" id="CD001861-sec-0001">Background</h3> <p>Recurrent corneal erosion is a common cause of disabling ocular symptoms and predisposes the cornea to infection. It may follow corneal trauma. Measures to prevent the development of recurrent corneal erosion following corneal trauma have not been firmly established. Once recurrent corneal erosion develops, simple medical therapy (standard treatment) may lead to resolution of the episode. However, some people continue to suffer when such therapy fails and repeated episodes of erosion develop. A number of treatment and prophylactic options are then available but there is no agreement as to the best option. This review version is an update to the original version published in 2007 and a previous update published in 2012. </p> </section> <section id="CD001861-sec-0002"> <h3 class="title" id="CD001861-sec-0002">Objectives</h3> <p>To assess the effectiveness and adverse effects of regimens for the prophylaxis of further recurrent corneal erosion episodes, the treatment of recurrent corneal erosion and prophylaxis of the development of recurrent corneal erosion following trauma. </p> </section> <section id="CD001861-sec-0003"> <h3 class="title" id="CD001861-sec-0003">Search methods</h3> <p>We searched CENTRAL, which contains the Cochrane Eyes and Vision Trials Register; MEDLINE; Embase; LILACS; the ISRCTN registry; ClinicalTrials.gov and the ICTRP. The date of the search was 14 December 2017. </p> </section> <section id="CD001861-sec-0004"> <h3 class="title" id="CD001861-sec-0004">Selection criteria</h3> <p>We included randomised and quasi‐randomised trials that compared a prophylactic or treatment regimen with another prophylaxis/treatment or no prophylaxis/treatment for people with recurrent corneal erosion. </p> </section> <section id="CD001861-sec-0005"> <h3 class="title" id="CD001861-sec-0005">Data collection and analysis</h3> <p>We used standard methods expected by Cochrane. Two authors independently screened search results, extracted data and assessed risk of bias in the included studies using the Cochrane tool for assessing risk of bias. We considered the following outcome measures: resolution of symptoms after treatment; recurrence after complete or partial resolution; symptoms (pain); adverse effects (corneal haze, astigmatism). We graded the certainty of the evidence using GRADE for the three most clinically relevant comparisons. </p> </section> <section id="CD001861-sec-0006"> <h3 class="title" id="CD001861-sec-0006">Main results</h3> <p>We included eight randomised and two quasi‐randomised controlled trials in the review, encompassing 505 participants. Seven studies were from Europe (Germany, Sweden and the UK), two from East Asia (Hong Kong and Japan) and one from Australia. Nine of the studies examined treatments for episodes of recurrent corneal erosions and one study considered prophylaxis to prevent development of recurrent corneal erosions after injury. Two of the nine treatment studies also enrolled participants in a study of prophylaxis to prevent further episodes of recurrent corneal erosions. The studies were poorly reported; we judged only one study low risk of bias on all domains. </p> <p>Two studies compared therapeutic contact lens with topical lubrication but one of these studies was published over 30 years ago and used a therapeutic contact lens that is no longer in common use. The more recent study was a two‐centre UK study with 29 participants. It provided low‐certainty evidence on resolution of symptoms after treatment with similar number of participants in both groups experiencing resolution of symptoms at four months (risk ratio (RR) 0.97, 95% confidence interval (CI) 0.62 to 1.53). There was very low‐certainty evidence on recurrence after partial or total resolution at seven months' follow‐up (RR 1.07, 95% CI 0.07 to 15.54). There was no evidence of an important difference in pain score (score of 3 in the contact lens group and score of 2 in the topical lubrication group, low‐certainty evidence) and no adverse effects were reported. The older study, using a contact lens no longer in common use, found an increased risk of pain and complications with the contact lens compared with hypromellose drops and paraffin ointment at night. </p> <p>A single‐centre, Australian study, with 33 participants, provided low‐certainty evidence of an increased risk of recurrence with phototherapeutic keratectomy compared with alcohol delamination but with wide confidence intervals, compatible with increased or decreased risk (RR 1.27, 95% CI 0.48 to 3.37). Time to recurrence was similar in both groups (6.5 and 6 months, low‐certainty evidence). On average people receiving phototherapeutic keratectomy reported less pain but confidence intervals included no difference or greater pain (mean difference (MD) ‐0.70, 95% CI ‐2.23 to 0.83, low‐certainty evidence). No adverse effects were reported. </p> <p>A 48‐participant study in Hong Kong found recurrences were less common in people given diamond burr superficial keratectomy after epithelial debridement compared with sham diamond burr treatment after epithelial debridement (RR 0.07, 95% CI 0.01 to 0.50, moderate‐certainty evidence). The study did not report pain scores but adverse effects such as corneal haze (RR 0.92, 95% CI 0.06 to 13.87, low‐certainty evidence) and astigmatism (0.88 versus 0.44 dioptres, moderate‐certainty evidence) were similar between the groups. </p> <p>A study comparing transepithelial versus subepithelial excimer laser ablation in 100 people found low‐certainty evidence of a small increased risk of recurrence of corneal erosion at one‐year follow‐up in people given the transepithelial compared with subepithelial technique, however, the confidence intervals were wide and compatible with increased or decreased risk (RR 1.20, 95% CI 0.58 to 2.48, low‐certainty evidence). Other outcomes were not reported. </p> <p>Other treatment comparisons included in this review were only addressed by studies published two decades or more ago. The results of these studies were inconclusive: excimer laser ablation (after epithelial debridement) versus no excimer laser ablation (after epithelial debridement), epithelial debridement versus anterior stromal puncture, anterior stromal puncture versus therapeutic contact lens, oral oxytetracycline and topical prednisolone (in addition to 'standard therapy') versus oral oxytetracycline (in addition to 'standard therapy') versus 'standard therapy'. </p> </section> <section id="CD001861-sec-0007"> <h3 class="title" id="CD001861-sec-0007">Authors' conclusions</h3> <p>Well‐designed, masked, randomised controlled trials using standardised methods are needed to establish the benefits of new and existing prophylactic and treatment regimes for recurrent corneal erosion. Studies included in this review have been of insufficient size and quality to provide firm evidence to inform the development of management guidelines. International consensus is also needed to progress research efforts towards evaluation of the major effective treatments for recurrent corneal erosions. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD001861-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001861-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD001861-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD001861-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ms#CD001861-abs-0006">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD001861-abs-0004">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD001861-abs-0010">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD001861-abs-0003" lang="en"> <h3>Prevention and treatment regimens for recurrent corneal erosion (corneal epithelial surface breakdown) </h3> <p><b>What is the aim of this review?</b><br/> The aim of this Cochrane Review was to find what treatment works best for recurrent corneal erosions and whether they can be prevented. Cochrane researchers collected and analysed all relevant studies to answer this question and found 10 studies. </p> <p><b>Key messages</b><br/> The review shows that there is a lack of good‐quality evidence to guide treatment decisions for recurrent corneal erosions. This is an evidence gap. </p> <p><b>What was studied in the review?</b><br/> The cornea is the clear front part of the eye. Sometimes the outermost layer of cells in the cornea (epithelium) breaks down and this can lead to repeated episodes of eye pain or discomfort, sensitivity to light, watering eyes and blurred vision. This is known as recurrent corneal erosion (RCEs). These symptoms can be disabling, and RCEs can make the eye more prone to infection. RCEs can happen after eye injury but are also a consequence of eye conditions, such as corneal dystrophy. </p> <p>Various treatments have been proposed and are used for RCEs. Eye drops moisten the eye (lubricants) or may contain antibiotics or steroids. Special contact lenses, known as therapeutic or bandage contact lenses, may be used. A section or layer of the cornea can be physically removed, which is known as debridement when the loose epithelium is removed, or superficial keratectomy when the epithelium and other material is removed. This can be done manually or using an 'excimer' laser (phototherapeutic). Sometimes the cornea is 'polished' afterwards using a tool called a diamond burr. This material can also be removed using alcohol (alcohol delamination). Small puncture holes, called anterior stromal punctures, may be made in the cornea with the aim of stabilising the epithelium. This can also be done with a laser. </p> <p><b>What are the main results of the review?</b><br/> Cochrane researchers found 10 relevant studies. Seven studies were from Europe (Germany, Sweden and the UK), two from East Asia (Hong Kong and Japan) and one from Australia. </p> <p>Two studies compared contact lens versus lubricant; single studies looked at phototherapeutic keratectomy versus alcohol delamination; diamond burr superficial keratectomy (after epithelial debridement) compared with epithelial debridement; two different techniques of laser removal of material (transepithelial versus subepithelial excimer laser ablation); contact lens compared with anterior stromal puncture; epithelial debridement compared with anterior stromal puncture; phototherapeutic keratectomy (after epithelial debridement) compared with epithelial debridement alone; and oral tetracycline compared with both topical prednisolone and standard therapy.<br/> <br/> Three studies (including two of the above treatment studies) compared different ways of preventing RCEs (prophylaxis). Two studies compared topical lubrication with no topical lubrication; and one study compared antibiotic ointment versus no antibiotic ointment. </p> <p>In general the studies included in this review were too small to provide conclusive results. More good‐quality randomised controlled trials are needed to guide the management of recurrent corneal erosions. </p> <p><b>How up to date is this review?</b><br/> Cochrane researchers searched for studies that had been published up to December 2017. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD001861-sec-0146" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD001861-sec-0146"></div> <h3 class="title" id="CD001861-sec-0147">Implications for practice</h3> <section id="CD001861-sec-0147"> <p>Randomised controlled trials have investigated a variety of prophylactic and therapeutic regimens to improve the clinical management of recurrent corneal erosion and to avert the development of recurrent corneal erosion following traumatic abrasion. Unfortunately the studies included in this review have been of insufficient quality to provide firm evidence to inform the development of management guidelines in recurrent corneal erosion. The studies to date have explored the different therapies that exist. This information could be used to provide people with information on the treatments available and their possible complications but not on their success or complication rates. The different treatment options have variable outcomes but the best method remains to be determined. </p> </section> <h3 class="title" id="CD001861-sec-0148">Implications for research</h3> <section id="CD001861-sec-0148"> <p>Investigators planning clinical studies in recurrent corneal erosion can use this review and its included studies to design studies to investigate the success and risks of different prophylactic and therapeutic regimens for recurrent corneal erosion. Future studies of recurrent corneal erosion should examine regimens to: </p> <p> <ol id="CD001861-list-0011"> <li> <p>avert the development of recurrent corneal erosion following traumatic corneal abrasion (prophylactic regimen). These studies should include people with traumatic corneal abrasions; </p> </li> <li> <p>prevent the occurrence of further episodes once a diagnosis of recurrent corneal erosion has been made (prophylactic regimen); and </p> </li> <li> <p>treat episodes of recurrent corneal erosion (treatment regimen).</p> </li> </ol> </p> <p>The latter two types of study should include people with recurrent corneal erosion occurring spontaneously, following corneal trauma, or with evidence of epithelial basement membrane dystrophy. Recurrent corneal erosion should be diagnosed based on the typical history of eye pain, watering and increased sensitivity to light on waking. A validated patient symptom questionnaire should be developed to allow the accurate identification of recurrent corneal erosion. Participants with any corneal dystrophy other than epithelial basement membrane dystrophy and with systemic diseases known to be associated with recurrent corneal erosion, such as epidermolysis bullosa, should be excluded. </p> <p>Medical and surgical treatments for recurrent corneal erosion, including excimer laser therapy, should be trialled. Such treatments should be compared to each other and to no treatment. Participants should be randomised into the treatment (or no treatment) groups and where possible both the participant and observer should be masked. Outcomes that should be measured include: </p> <p> <ol id="CD001861-list-0012"> <li> <p>recurrence after treatment (number in total, number improved and requiring further treatment, and time to recurrence); </p> </li> <li> <p>symptom recurrence and severity; and</p> </li> <li> <p>adverse effect data (including the best‐corrected visual acuity, conjunctival injection, intraocular pressure, development of cataract, refraction and occurrence of an ocular or systemic adverse event). </p> </li> </ol> </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD001861-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD001861-sec-0022"></div> <div class="table" id="CD001861-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Therapeutic contact lens versus topical lubrication for the treatment of recurrent corneal erosion syndrome</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Therapeutic contact lens versus topical lubrication</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population</b>: people with recurrent corneal erosion syndrome without previous surgical intervention </p> <p><b>Settings</b>: outpatient </p> <p><b>Intervention</b>: therapeutic contact lens </p> <p><b>Comparison</b>: topical lubrication </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Topical lubrication</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Therapeutic contact lens</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Resolution of symptoms after treatment</b> </p> <p>Follow‐up: 4 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>730 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>708 per 1000</p> <p>(453 to 1000)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.97 (0.62 to 1.53)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29 participants</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Recurrence after complete or partial resolution</b> </p> <p>Follow‐up: 7 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>67 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>72 per 1000</p> <p>(0 to 1000)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.07</p> <p>(0.07 to 15.54)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29 participants</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single study only followed up participants with complete resolution to screen for recurrence </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Time to recurrence</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Outcome not reported for this comparison</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Recurrences requiring further treatment</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Neither study reported this outcome but one study stated that the two recurrences were minor symptoms with no obvious macroerosions. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptoms (pain score)</b> </p> <p>Follow‐up: 3 months</p> <p>(higher score indicates more pain, unclear range of scale but probably 0 to 10)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean pain score with topical lubrication was <b>2</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean pain score with therapeutic contact lens was <b>1</b> higher (worse) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29 participants</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Visual analogue scale range not specified, standard deviations not reported</p> <p>One other study of 24 participants reported more pain in contact lens group (RR 3.15, 95% CI 1.10, 9.06) but contact lens used is no longer in common use </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse effects: corneal haze</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The more recent study did not report this outcome. The older study using a lens no longer in common use reported more complications with the contact lens. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse effects: astigmatism</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Outcome not reported for this comparison</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence</p> <p><b>High‐certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect. </p> <p><b>Moderate‐certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. </p> <p><b>Low‐certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect. </p> <p><b>Very low‐certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded one level for risk of bias due to serious limitation in study design and execution (the single study has a high risk of bias due to lack of blinding of study personnel).<br/> <sup>2</sup>Downgraded one level for imprecision.<br/> 3Downgraded two levels for imprecision (very few events).<br/> <sup>4</sup>Downgraded one level for indirectness as contact lens no longer in use. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD001861-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Phototherapeutic keratectomy versus alcohol delamination for the treatment of recurrent corneal erosion syndrome</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Phototherapeutic keratectomy versus alcohol delamination</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population</b>: people with recurrent corneal erosion syndrome without previous surgical intervention </p> <p><b>Settings</b>: outpatient </p> <p><b>Intervention</b>: phototherapeutic keratectomy (after epithelial debridement) </p> <p><b>Comparison</b>: alcohol delamination and sham excimer laser (after epithelial debridement) </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Alcohol delamination</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Phototherapeutic keratectomy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Resolution of symptoms after treatment</b> </p> <p>Follow‐up: 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>590 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>378 per 1000 (177 to 797)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.64 (0.30 to 1.35)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33 participants</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Recurrence after complete or partial resolution</b> </p> <p>Follow‐up: 24 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>294 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>373 per 1000</p> <p>(141 to 991)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 1.27</p> <p>(0.48 to 3.37)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33 participants</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>All participants were followed for recurrence up to 24 months</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time to recurrence</b> </p> <p>Follow‐up: 24 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean time to recurrence in the control group was</p> <p><b>6 months</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean time to recurrence in the intervention group was <b>0.5 months longer</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33 participants</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard deviations not reported but difference between groups was reported to be not statistically significant </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Recurrences requiring further treatment</b> </p> <p>Follow‐up: 24 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>176 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>125 per 1000</p> <p>(25 to 651)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.71</p> <p>(0.14 to 3.70)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33 participants</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>2,3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Further treatment of choice not indicated</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Symptoms (pain score)</b> </p> <p>(scale 0‐10)</p> <p>(lower scores indicate less pain)</p> <p>Follow‐up: 24 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean pain score in the control group was<b>1.7</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean pain score in the intervention group was <b>0.7 lower</b> (2.23 lower to 0.83 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33 participants</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse effects: corneal haze</b> </p> <p>Follow‐up: 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign=""> <p>There were no events in either group.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33 participants</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>2,3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse effects: astigmatism</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>Outcome not reported for this comparison</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence</p> <p><b>High‐certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect. </p> <p><b>Moderate‐certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. </p> <p><b>Low‐certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect. </p> <p><b>Very low‐certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded one level for imprecision: small sample size<br/> <sup>2</sup>Downgraded one level for limitation in design and execution: the single study has a high risk of bias due to lack of blinding of study personnel<br/> <sup>3</sup>Downgraded two levels for imprecision: small sample size, very few or no events </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD001861-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Diamond burr superficial keratectomy (after epithelial debridement) versus sham diamond burr (after epithelial debridement) for the treatment of recurrent corneal erosion syndrome</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Diamond burr superficial keratectomy (after epithelial debridement) versus sham diamond burr (after epithelial debridement)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population</b>: people with recurrent corneal erosion syndrome without other corneal basement membrane dystrophy </p> <p><b>Settings</b>: outpatient </p> <p><b>Intervention</b>: diamond burr superficial keratectomy after epithelial debridement </p> <p><b>Comparison</b>: sham diamond burr superficial keratectomy after epithelial debridement </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Sham diamond burr superficial keratectomy after epithelial debridement</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Diamond burr superficial keratectomy after epithelial debridement</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Resolution of symptoms after treatment</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>Outcome not reported for this comparison</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Recurrence after complete or partial resolution</b> </p> <p>Follow‐up: 6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>565 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>40 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.07 (0.01 to 0.50)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48 participants</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single study reported major recurrence defined as those requiring ophthalmologist assessment </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time to recurrence</b> </p> <p>Follow‐up: 6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean time to recurrence with sham diamond burr was <b>2.4 months</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean time to recurrence in the intervention group was <b>3.6 months longer</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48 participants</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Only one event in diamond burr group</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Recurrences requiring further treatment</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>Outcome not reported for this comparison</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Symptoms (pain score)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>Outcome not reported for this comparison</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse effects: corneal haze</b> </p> <p>Follow‐up: 6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>43 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>40 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.92 (0.06‐13.87)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48 participants</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Four point scale was used to grade degree of haze (absent, mild, moderate, severe). Single study reported 1 mild haze and 1 moderate in the control and intervention groups respectively. Haze was analysed as dichotomous variable. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse effects: astigmatism</b> (mean magnitude) measured in dioptres. Higher value is worse astigmatism. </p> <p>Follow‐up: 3 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean astigmatism in the sham diamond burr group was <b>0.88 dioptres</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean astigmatism in the diamond burr group was <b>0.44 dioptres less (better)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48 participants</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No standard deviations available</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence</p> <p><b>High‐certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect. </p> <p><b>Moderate‐certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. </p> <p><b>Low‐certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect. </p> <p><b>Very low‐certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded one level for imprecision: small sample size ‐ did not reach target sample size per included power calculations.<br/> <sup>2</sup> Downgraded two levels for imprecision: small sample size ‐ did not reach target sample size per included power calculations, unable to estimate event rate.<br/> <sup>3</sup> Downgraded two levels for imprecision: small sample size ‐ did not reach target sample size per included power calculations, wide confidence interval. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD001861-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD001861-sec-0023"></div> <section id="CD001861-sec-0024"> <h3 class="title" id="CD001861-sec-0024">Description of the condition</h3> <p>Recurrent corneal erosion is a relatively common clinical disorder that is characterised by repeated episodes of breakdown of the corneal epithelium (<a href="./references#CD001861-bbs2-0016" title="BrownN , BronA . Recurrent erosion of the cornea. British Journal of Ophthalmology1976;60(2):84‐96. ">Brown 1976</a>; <a href="./references#CD001861-bbs2-0017" title="ChandlerPA . Recurrent erosions of the cornea. American Journal of Ophthalmology1945;28:355‐63. ">Chandler 1945</a>). Erosions can occur spontaneously, following superficial corneal injury, in certain corneal dystrophies (such as epithelial basement membrane (map‐dot‐fingerprint) dystrophy or lattice dystrophy), and in systemic illnesses such as epidermolysis bullosa. People with this condition experience repeated episodes of ocular discomfort and blurred vision and some may require prolonged therapy (<a href="./references#CD001861-bbs2-0024" title="HeyworthP , MorletN , RaynerS , HykinP , DartJ . Natural history of recurrent erosion syndrome ‐ a 4 year review of 117 patients. British Journal of Ophthalmology1998;82(1):26‐8. ">Heyworth 1998</a>). Abnormal formation of hemidesmosomes or anchoring filaments (cellular attachments) at the basal layer of the corneal epithelium are believed to play an important role in the pathogenesis of recurrent corneal erosion (<a href="./references#CD001861-bbs2-0039" title="WoodTO . Recurrent erosion. Transactions of the American Ophthalmological Society1984;82:850‐98. ">Wood 1984</a>). Matrix metalloproteinases (extracellular proteolytic enzymes) may have a role in degrading epithelial cell attachments (<a href="./references#CD001861-bbs2-0020" title="DursunD , KimMC , SolomonA , PflugfelderSC . Treatment of recalcitrant recurrent corneal erosions with inhibitors of matrix metalloproteinase‐9, doxycycline and corticosteroids. American Journal of Ophthalmology2001;132(1):8‐13. ">Dursun 2001</a>). <a href="./references#CD001861-bbs2-0015" title="BernauerW , deCockR , DartJ . Phototherapeutic keratectomy in recurrent corneal erosions refractory to other forms of treatment. Eye1996;10(5):561‐4. ">Bernauer 1996</a> and colleagues proposed that the lids may adhere to the cornea overnight due to thinning of the tear film. A shearing force on the corneal epithelium may then occur due to movement of the lid on waking or of the eye during rapid eye movement sleep thus producing a corneal erosion. </p> <p>The incidence and prevalence of recurrent corneal erosion is not known with certainty. In a retrospective case series of 104 people with recurrent corneal erosion a history of trauma was reported in around half of them, epithelial basement membrane dystrophy in around a third of them and the majority of the remaining people had a history of both trauma and epithelial basement membrane dystrophy (<a href="./references#CD001861-bbs2-0036" title="ReidyJJ , PaulusMP , GonaS . Recurrent erosion of the cornea: epidemiology and treatment. Cornea2000;19(6):767‐71. ">Reidy 2000</a>). The mean age of presentation has been reported as 43 years (range 14 to 77 years) with a preponderance of recurrent corneal erosion in women (<a href="./references#CD001861-bbs2-0036" title="ReidyJJ , PaulusMP , GonaS . Recurrent erosion of the cornea: epidemiology and treatment. Cornea2000;19(6):767‐71. ">Reidy 2000</a>). Traumatic corneal abrasion, a leading precipitating cause for recurrent corneal erosion, is one of the commonest causes for attendance in eye casualty and general emergency departments (<a href="./references#CD001861-bbs2-0030" title="JonesNP , HaywardJM , KhawPT , ClaoueCM , ElkingtonAR . Function of an ophthalmic 'accident and emergency' department: results of a 6 month study. Brtish Medical Journal1986;292(6514):188‐90. ">Jones 1986</a>). The incidence of recurrent corneal erosion following traumatic corneal abrasion has been estimated at one in 150 cases (<a href="./references#CD001861-bbs2-0029" title="JacksonH . The effect of eyepads on the healing of simple corneal abrasions. British Medical Journal1960;5200:713. ">Jackson 1960</a>). </p> <p>Recurrent corneal erosion is typically diagnosed on the basis of a clinical history of repeated episodes of ocular discomfort that develops with or without a prior corneal epithelial abrasion or injury. Patients will report episodes of pain, watering of the eye, increased sensitivity to light and blurring of vision, typically on waking. These episodes are interspersed with periods where the eye is relatively quiet or completely asymptomatic. The characteristic complaint is of early morning eye pain with or without preceding trauma (<a href="./references#CD001861-bbs2-0039" title="WoodTO . Recurrent erosion. Transactions of the American Ophthalmological Society1984;82:850‐98. ">Wood 1984</a>). Symptoms result from the breakdown of the corneal epithelium. Erosions can resolve quickly and may be missed on examination. </p> <p>Two types of recurrent corneal erosion have been described (<a href="./references#CD001861-bbs2-0017" title="ChandlerPA . Recurrent erosions of the cornea. American Journal of Ophthalmology1945;28:355‐63. ">Chandler 1945</a>). In the macroform type (macroerosions) there is extensive loss of corneal epithelium accompanied by severe symptoms that may take several days to resolve. In the microform type (microerosions) there is a small area of epithelial loss; this type of erosion occurs more frequently but is milder and of shorter duration (<a href="./references#CD001861-bbs2-0017" title="ChandlerPA . Recurrent erosions of the cornea. American Journal of Ophthalmology1945;28:355‐63. ">Chandler 1945</a>; <a href="./references#CD001861-bbs2-0039" title="WoodTO . Recurrent erosion. Transactions of the American Ophthalmological Society1984;82:850‐98. ">Wood 1984</a>). However, this terminology is not in routine clinical use and there is evidence that there is no clear distinction between these types of recurrent corneal erosion (<a href="./references#CD001861-bbs2-0016" title="BrownN , BronA . Recurrent erosion of the cornea. British Journal of Ophthalmology1976;60(2):84‐96. ">Brown 1976</a>). </p> <p>There are no specific diagnostic tests for recurrent corneal erosion. Signs of recurrent corneal erosion are best visualised with slit‐lamp examination using a cobalt‐blue light following the instillation of topical fluorescein. A frank epithelial defect or loose epithelium will be seen (<a href="./references#CD001861-bbs2-0036" title="ReidyJJ , PaulusMP , GonaS . Recurrent erosion of the cornea: epidemiology and treatment. Cornea2000;19(6):767‐71. ">Reidy 2000</a>). In some patients clinical signs or evidence of an underlying epithelial basement membrane disorder such as microcysts and epithelial lines may aid the diagnosis (<a href="./references#CD001861-bbs2-0017" title="ChandlerPA . Recurrent erosions of the cornea. American Journal of Ophthalmology1945;28:355‐63. ">Chandler 1945</a>; <a href="./references#CD001861-bbs2-0039" title="WoodTO . Recurrent erosion. Transactions of the American Ophthalmological Society1984;82:850‐98. ">Wood 1984</a>). Meibomian gland dysfunction has been reported to co‐exist in people with recalcitrant recurrent corneal erosion (<a href="./references#CD001861-bbs2-0027" title="Hope‐RossMW , ChellPB , KervickGN , McDonnellPJ . Recurrent corneal erosion: clinical features. Eye1994;8(Pt 4):373‐7. ">Hope‐Ross 1994a</a>). </p> </section> <section id="CD001861-sec-0025"> <h3 class="title" id="CD001861-sec-0025">Description of the intervention</h3> <p>Simple medical therapy may be used, for example, ointment at night following traumatic corneal abrasion (<a href="./references#CD001861-bbs2-0003" title="EkeT , MorrisonDA , AustinDJ . Recurrent symptoms following traumatic corneal abrasion: prevalence, severity, and the effect of a simple regimen of prophylaxis. Eye1999;13(Pt 3a):345‐7. ">Eke 1999</a>). </p> <p>Standard (empirical) therapy involves topical ointments, patching of the eye, dilation of the pupil and topical antibiotics, used alone or in combination (<a href="./references#CD001861-bbs2-0003" title="EkeT , MorrisonDA , AustinDJ . Recurrent symptoms following traumatic corneal abrasion: prevalence, severity, and the effect of a simple regimen of prophylaxis. Eye1999;13(Pt 3a):345‐7. ">Eke 1999</a>; <a href="./references#CD001861-bbs2-0027" title="Hope‐RossMW , ChellPB , KervickGN , McDonnellPJ . Recurrent corneal erosion: clinical features. Eye1994;8(Pt 4):373‐7. ">Hope‐Ross 1994a</a>; <a href="./references#CD001861-bbs2-0006" title="HykinPG , FossAE , PavesioC , DartJK . The natural history and management of recurrent corneal erosion: a prospective randomised trial. Eye1994;8(Pt 1):35‐40. ">Hykin 1994</a>). Their adverse effects or effectiveness have not been established in clinical trials. A Cochrane Review found that patching simple corneal abrasions, following trauma or a foreign body, does not improve healing rates or reduce pain (<a href="./references#CD001861-bbs2-0031" title="LimCHL , TurnerA , LimBX . Patching for corneal abrasion. Cochrane Database of Systematic Reviews2016, Issue 7. [DOI: 10.1002/14651858.CD004764.pub3] ">Lim 2016</a>). </p> <p>Alternative strategies, when the above do not work, include the following.</p> <p> <ol id="CD001861-list-0001"> <li> <p>Removal of the loose epithelium by mechanical debridement, superficial keratectomy or excimer laser phototherapeutic keratectomy (PTK) (<a href="./references#CD001861-bbs2-0033" title="MainiR , LoughmanMS . Phototherapeutic keratectomy re‐treatment for recurrent corneal erosion syndrome. British Journal of Ophthalmology2002;86(3):270‐2. ">Maini 2002</a>; <a href="./references#CD001861-bbs2-0007" title="OhmanL , FagerholmP . The influence of excimer laser ablation on recurrent corneal erosions: a prospective randomized study. Cornea1998;17(4):349‐52. ">Ohman 1998</a>). Diamond burr polishing produces fewer recurrences compared to simple epithelial debridement (<a href="./references#CD001861-bbs2-0009" title="WongVW , ChiSC , LamDS . Diamond burr polishing for recurrent corneal erosions:results from a prospective randomized controlled trial. Cornea2009;28(2):152‐6. ">Wong 2009</a>). Alcohol delamination (<a href="./references#CD001861-bbs2-0019" title="DuaHS , LagnadoR , RajD , SinghR , MantryS , GrayT . Alcohol delamination of the corneal epithelium: an alternative in the management of recurrent corneal erosions. Ophthalmology2006;113(3):404‐11. ">Dua 2006</a>; <a href="./references#CD001861-bbs2-0038" title="SinghRP , RajD , PherwaniA , LagnadoR , AbedinA , EatamadiH , et al. Alcohol delamination of the corneal epithelium for recalcitrant recurrent corneal erosion syndrome: a prospective study of efficacy and safety. British Journal of Ophthalmology2007;91(7):908‐11. ">Singh 2007</a>) has been described as a safer and less invasive procedure compared to mechanical or laser debridement. </p> </li> <li> <p>A therapeutic contact lens has been used for recalcitrant recurrent erosion involving the visual axis. </p> </li> <li> <p>Nd:YAG laser treatment, needle anterior stromal puncture or microdiathermy have been used to promote epithelial stability via the production of subepithelial scar tissue (<a href="./references#CD001861-bbs2-0021" title="GeggelHS . Successful treatment of recurrent corneal erosion with Nd:YAG anterior stromal puncture. American Journal of Ophthalmology1990;110(4):404‐7. ">Geggel 1990</a>; <a href="./references#CD001861-bbs2-0034" title="McLeanE , MacRaeSM , RichLF . Recurrent erosion: treatment by anterior stromal puncture. Ophthalmology1986;93(6):784‐8. ">McLean 1986</a>; <a href="./references#CD001861-bbs2-0039" title="WoodTO . Recurrent erosion. Transactions of the American Ophthalmological Society1984;82:850‐98. ">Wood 1984</a>). </p> </li> <li> <p>Oral tetracycline 250 mg twice daily for 12 weeks or topical prednisolone 0.5% four times daily for seven days, or both (<a href="./references#CD001861-bbs2-0004" title="Hope‐RossMW , ChellPB , KervickGN , McDonnellPJ , JonesHS . Oral tetracycline in the treatment of recurrent corneal erosions. Eye1994;8(Pt 4):384‐8. ">Hope‐Ross 1994</a>), or oral doxycycline 50 mg twice daily and topical corticosteroid (either methylprednisolone 1%, prednisolone acetate 1% or fluoromethalone 0.1%) three times a day for two to three weeks (<a href="./references#CD001861-bbs2-0020" title="DursunD , KimMC , SolomonA , PflugfelderSC . Treatment of recalcitrant recurrent corneal erosions with inhibitors of matrix metalloproteinase‐9, doxycycline and corticosteroids. American Journal of Ophthalmology2001;132(1):8‐13. ">Dursun 2001</a>) have been added to standard treatment regimens. Autologous serum eye drops three to eight times per day for three to six months have been used in patients not improving on the standard therapy or for whom antibiotic therapy has failed, or both (<a href="./references#CD001861-bbs2-0018" title="delCastilloJM , de laCasaJM , SardinaRC , FernandezRM , FeijooJG , GomezAC , et al. Treatment of recurrent corneal erosions using autologous serum. Cornea2002;21(8):781‐3. ">del Castillo 2002</a>; <a href="./references#CD001861-bbs2-0014" title="ZiakasNG , BoboridisKG , TerzidouC , NaoumidiTL , MikropoulosD , GeorgiadouEN , et al. Long‐term follow up of autologous serum treatment for recurrent corneal erosions. Clinical and Experimental Ophthalmology2010;38(7):683‐7. ">Ziakas 2010</a>). </p> </li> </ol> </p> </section> <section id="CD001861-sec-0026"> <h3 class="title" id="CD001861-sec-0026">How the intervention might work</h3> <p>The standard treatments are given on the basis of symptomatic relief and prophylaxis for infection. The theoretical basis of the alternative therapies is outlined below. </p> <p> <ol id="CD001861-list-0002"> <li> <p>Removal of loose epithelium by mechanical debridement, superficial keratectomy or PTK. This is thought to strengthen the adhesion of the basal epithelial cells to the basement membrane (<a href="./references#CD001861-bbs2-0033" title="MainiR , LoughmanMS . Phototherapeutic keratectomy re‐treatment for recurrent corneal erosion syndrome. British Journal of Ophthalmology2002;86(3):270‐2. ">Maini 2002</a>; <a href="./references#CD001861-bbs2-0007" title="OhmanL , FagerholmP . The influence of excimer laser ablation on recurrent corneal erosions: a prospective randomized study. Cornea1998;17(4):349‐52. ">Ohman 1998</a>). Alcohol delamination is thought to be a superior method because it does not seem to disrupt the lamina lucida (<a href="./references#CD001861-bbs2-0035" title="MencucciR , PaladiniI , BrahimiB , MenchiniU , DuaHS , RomagnoliP . Alcohol delamination in the treatment of recurrent corneal erosion: an electron microscopic study. British Journal of Ophthalmology2010;94(7):933‐9. ">Menucci 2010</a>) and therefore has a reduced risk of excessive scarring or alteration of the optical properties of the cornea, or both. </p> </li> <li> <p>A therapeutic contact lens may protect the epithelium from the shearing force of the lids but requires monitoring of the patient for microbial keratitis (<a href="./references#CD001861-bbs2-0032" title="LiuC , BuckleyR . The role of the therapeutic contact lens in the management of recurrent corneal erosions: a review of treatment strategies. Contact Lens Association of Ophthalmologists1996;22(1):79‐82. ">Liu 1996</a>; <a href="./references#CD001861-bbs2-0008" title="WilliamsR , BuckleyRJ . Pathogenesis and treatment of recurrent erosion. British Journal of Ophthalmology1985;69(6):435‐7. ">Williams 1985</a>). </p> </li> <li> <p>The production of subepithelial scar tissue is thought to strengthen the junction between epithelium and basement membrane. It has been observed that eyes with penetrating corneal injuries are less likely to get recurrent corneal erosion as a complication. </p> </li> <li> <p>Oral tetracyclines and topical steroid regimens are thought to inhibit matrix metalloproteinases and hence reduce protein breakdown to preserve the bond between the epithelium and basement membrane. </p> </li> <li> <p>Autologous serum therapy is thought to provide fibronectin, which promotes epithelial migration and anchorage. </p> </li> </ol> </p> </section> <section id="CD001861-sec-0027"> <h3 class="title" id="CD001861-sec-0027">Why it is important to do this review</h3> <p>Recurrent corneal erosion is a common, painful and debilitating ocular condition. However, as the many different prophylactic and treatment options available suggest, there is no agreement as to the best management. In this review we aimed to analyse evidence from randomised trials to determine the risks and benefits of prophylactic and treatment modalities available for recurrent corneal erosion. However, as different therapies have been trialled for the prophylaxis and treatment of recurrent corneal erosion episodes and for averting the occurrence of recurrent corneal erosion after a corneal injury, we analysed the studies on recurrent corneal erosion in three groups. Regimens to: </p> <p> <ol id="CD001861-list-0003"> <li> <p>avert the development of recurrent corneal erosion following a traumatic corneal erosion (prophylaxis of the development of recurrent corneal erosion); </p> </li> <li> <p>treat episodes of recurrent corneal erosion (treatment of recurrent corneal erosion); and </p> </li> <li> <p>prevent the occurrence of further episodes once a diagnosis of recurrent corneal erosion has been made (prophylaxis of further episodes of recurrent corneal erosion). </p> </li> </ol> </p> <p>This current review is an update to the original version published in 2007 and a previous update published in 2012. Both previous versions of the review concluded that there is a need for well‐designed, masked, randomised controlled trials using standardised methods to establish the benefits of new and existing prophylactic and treatment regimens for recurrent corneal erosion. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD001861-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD001861-sec-0028"></div> <p>To assess the effectiveness and adverse effects of regimens for the prophylaxis of further recurrent corneal erosion episodes, the treatment of recurrent corneal erosion and prophylaxis of the development of recurrent corneal erosion following trauma. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD001861-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD001861-sec-0029"></div> <section id="CD001861-sec-0030"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD001861-sec-0031"> <h4 class="title">Types of studies</h4> <p>We included randomised and quasi‐randomised trials.</p> </section> <section id="CD001861-sec-0032"> <h4 class="title">Types of participants</h4> <p>Participants in the studies were:</p> <p> <ol id="CD001861-list-0004"> <li> <p>people with recurrent corneal erosion occurring spontaneously, following corneal trauma, or with evidence of epithelial basement dystrophy; or </p> </li> <li> <p>people with traumatic corneal abrasions.</p> </li> </ol> </p> <p>The diagnosis of recurrent corneal erosion was based on the typical history of eye pain and watering with increased sensitivity to light on waking. We excluded studies that included participants with any corneal dystrophy other than epithelial basement membrane dystrophy and with systemic diseases known to be associated with recurrent corneal erosion, such as epidermolysis bullosa. </p> </section> <section id="CD001861-sec-0033"> <h4 class="title">Types of interventions</h4> <p>We included studies that compared any of the following types of prophylactic or treatment regimens: ointment (lubricant, tetracycline, hypertonic saline) at night, other topical therapy (topical prednisolone, lubricants), oral tetracycline, anterior stromal puncture, manual debridement, excimer laser ablation and therapeutic contact lenses. We also included studies that compared one of these interventions to no intervention. These regimens were employed to: </p> <p> <ol id="CD001861-list-0005"> <li> <p>avert the development of recurrent corneal erosion following traumatic corneal abrasion (prophylactic regimen); </p> </li> <li> <p>prevent the occurrence of further episodes once a diagnosis of recurrent corneal erosion had been made (prophylactic regimen); and </p> </li> <li> <p>treat episodes of recurrent corneal erosion (treatment regimen).</p> </li> </ol> </p> </section> <section id="CD001861-sec-0034"> <h4 class="title">Types of outcome measures</h4> <p>We considered the following outcome measures:</p> <p> <ol id="CD001861-list-0006"> <li> <p>resolution of symptoms after treatment (number in total, total number of erosions, time to resolution); </p> </li> <li> <p>recurrence after complete or partial resolution (number in total, time to recurrence, recurrences requiring further treatment); </p> </li> <li> <p>symptoms (pain); and</p> </li> <li> <p>adverse effects (corneal haze, astigmatism).</p> </li> </ol> </p> <p>Outcome 1 was not relevant to the prophylaxis regimen.</p> </section> </section> <section id="CD001861-sec-0035"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD001861-sec-0036"> <h4 class="title">Electronic searches</h4> <p>The Cochrane Eyes and Vision Information Specialist conducted systematic searches in the following databases for randomised controlled trials and controlled clinical trials. There were no language or publication year restrictions. The date of the search was 14 December 2017. </p> <p> <ol id="CD001861-list-0007"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; 2017, Issue 11) (which contains the Cochrane Eyes and Vision Trials Register) in the Cochrane Library (searched 14 December 2017) (<a href="./appendices#CD001861-sec-0152">Appendix 1</a>). </p> </li> <li> <p>MEDLINE Ovid (1946 to 14 December 2017) (<a href="./appendices#CD001861-sec-0153">Appendix 2</a>). </p> </li> <li> <p>Embase Ovid (1980 to 14 December 2017) (<a href="./appendices#CD001861-sec-0154">Appendix 3</a>). </p> </li> <li> <p>LILACS (1982 to 14 December 2017) (<a href="./appendices#CD001861-sec-0155">Appendix 4</a>). </p> </li> <li> <p>ISRCTN registry (<a href="http://www.isrctn.com/editAdvancedSearch" target="_blank">www.isrctn.com/editAdvancedSearch</a>; searched 14 December 2017) (<a href="./appendices#CD001861-sec-0156">Appendix 5</a>). </p> </li> <li> <p>US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>; searched 14 December 2017) (<a href="./appendices#CD001861-sec-0157">Appendix 6</a>). </p> </li> <li> <p>World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP)(<a href="http://www.who.int/ictrp" target="_blank">www.who.int/ictrp</a>; searched 14 December 2017) (<a href="./appendices#CD001861-sec-0158">Appendix 7</a>). </p> </li> </ol> </p> </section> <section id="CD001861-sec-0037"> <h4 class="title">Searching other resources</h4> <p>We used the Science Citation Index to search for studies that cited the studies included in this review. We searched the reference lists of reports of studies that were selected for inclusion. We contacted experts in the field to ask if they were aware of any other relevant published or unpublished studies. </p> </section> </section> <section id="CD001861-sec-0038"> <h3 class="title" id="CD001861-sec-0038">Data collection and analysis</h3> <section id="CD001861-sec-0039"> <h4 class="title">Selection of studies</h4> <p>The review authors independently checked the titles and abstracts identified from the electronic and bibliographic searches and from contact with experts. We obtained the full texts of possibly relevant papers. Each review author assessed the studies according to the inclusion criteria for this review. We resolved disagreements by discussion. We assessed selected studies for methodological quality. </p> </section> <section id="CD001861-sec-0040"> <h4 class="title">Data extraction and management</h4> <p>The review authors independently extracted data using a form developed by Cochrane Eyes and Vision. We compared the results and resolved discrepancies. We contacted the authors of reports to obtain missing data. </p> </section> <section id="CD001861-sec-0041"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>The review authors assessed study quality according to the Cochrane Eyes and Vision Review Development Guidelines based on Chapter 8 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD001861-bbs2-0025" title="HigginsJP , AltmanDG , Sterne JACeditor(s) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011a</a>). The review authors were not masked to the report authors and study results during the assessment. We resolved disagreements by discussion. We considered four parameters: allocation concealment and method of allocation to treatment (selection bias), masking of participants and examiners (performance bias and detection bias) and exclusions after randomisation and losses to follow‐up (attrition bias). We assessed each parameter of study quality according to the 'Risk of bias' table and judged as 'low risk', 'high risk' or 'unclear risk'. We contacted authors of studies that were unclear on any parameter for clarification of details. </p> </section> <section id="CD001861-sec-0042"> <h4 class="title">Data synthesis</h4> <p>We calculated outcome measures of effect across studies and expressed the results as risk ratios (RR) and 95% confidence intervals (CI) for dichotomous outcomes and mean difference (MD) and 95% CI for continuous outcomes. We were unable to pool the studies as there was significant clinical heterogeneity between the studies. We have provided a descriptive summary of the results. </p> <section id="CD001861-sec-0043"> <h5 class="title">'Summary of findings' tables</h5> <p>We selected the three most clinically relevant treatment comparisons for the 'Summary of findings' tables and GRADE assessment. The comparisons selected includes: </p> <p> <ol id="CD001861-list-0008"> <li> <p>Therapeutic contact lens versus topical lubrication for the treatment of recurrent corneal erosion syndrome </p> </li> <li> <p>Phototherapeutic keratectomy versus alcohol delamination for the treatment of recurrent corneal erosion syndrome </p> </li> <li> <p>Diamond burr superficial keratectomy (after epithelial debridement) versus sham diamond burr (after epithelial debridement) for the treatment of recurrent corneal erosion syndrome </p> </li> </ol> </p> <p>We included the following outcomes:</p> <p> <ol id="CD001861-list-0009"> <li> <p>resolution of symptoms after treatment</p> </li> <li> <p>recurrence after complete or partial resolution</p> </li> <li> <p>time to recurrence</p> </li> <li> <p>recurrences requiring further treatment</p> </li> <li> <p>symptoms (pain score)</p> </li> <li> <p>adverse effects (corneal haze)</p> </li> <li> <p>adverse effects (astigmatism)</p> </li> </ol> </p> <p>We used a two‐author consensus to assess the certainty of the body of evidence in accordance to the five GRADE considerations (study limitations, consistency of effect, imprecision, indirectness, publication bias) (<a href="./references#CD001861-bbs2-0023" title="McMaster University (developed by Evidence Prime). GRADEpro GDT. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. ">GRADEpro GDT 2015</a>). We justified any decisions to downgrade or upgrade certainty of evidence through explanatory footnotes and highlighted important considerations in the 'Comments' column. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD001861-sec-0044" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD001861-sec-0044"></div> <section id="CD001861-sec-0045"> <h3 class="title">Description of studies</h3> <section id="CD001861-sec-0046"> <h4 class="title">Results of the search</h4> <p>The original electronic search conducted in June 2007, retrieved 1217 titles and abstracts. We obtained the full‐text copies of seven papers of possible relevance (<a href="http://archie.cochrane.org/sections/documents/view?version=F811CFED82E26AA201A2F2798F704785%26format=REVMAN#STD-Arbour-1997" target="_blank">Arbour 1997</a>; <a href="http://archie.cochrane.org/sections/documents/view?version=F811CFED82E26AA201A2F2798F704785%26format=REVMAN#STD-Eke-1999" target="_blank">Eke 1999</a>; <a href="http://archie.cochrane.org/sections/documents/view?version=F811CFED82E26AA201A2F2798F704785%26format=REVMAN#STD-Hope_x002d_Ross-1994" target="_blank">Hope‐Ross 1994</a>; <a href="http://archie.cochrane.org/sections/documents/view?version=F811CFED82E26AA201A2F2798F704785%26format=REVMAN#STD-Hykin-1994" target="_blank">Hykin 1994</a>; <a href="http://archie.cochrane.org/sections/documents/view?version=F811CFED82E26AA201A2F2798F704785%26format=REVMAN#STD-Ohman-1998" target="_blank">Ohman 1998</a>; <a href="http://archie.cochrane.org/sections/documents/view?version=F811CFED82E26AA201A2F2798F704785%26format=REVMAN#STD-Williams-1985" target="_blank">Williams 1985</a>; <a href="http://archie.cochrane.org/sections/documents/view?version=F811CFED82E26AA201A2F2798F704785%26format=REVMAN#STD-Yamada-1998" target="_blank">Yamada 1998</a>). These described randomised or quasi‐randomised controlled studies comparing therapies for recurrent corneal erosions. One paper was translated into English from Japanese (<a href="http://archie.cochrane.org/sections/documents/view?version=F811CFED82E26AA201A2F2798F704785%26format=REVMAN#STD-Yamada-1998" target="_blank">Yamada 1998</a>). One study (<a href="http://archie.cochrane.org/sections/documents/view?version=F811CFED82E26AA201A2F2798F704785%26format=REVMAN#STD-Arbour-1997" target="_blank">Arbour 1997</a>) randomised and analysed recurrent corneal erosions and traumatic erosions together. We received no response from our letter to the authors requesting subgroup data so this paper was excluded (see <a href="http://archie.cochrane.org/sections/documents/view?version=F811CFED82E26AA201A2F2798F704785%26format=REVMAN#CHARACTERISTICS_OF_EXCLUDED_STUDIES" target="_blank">Characteristics of excluded studies</a> table). A total of six studies were included in the review (see <a href="http://archie.cochrane.org/sections/documents/view?version=F811CFED82E26AA201A2F2798F704785%26format=REVMAN#CHARACTERISTICS_OF_INCLUDED_STUDIES" target="_blank">Characteristics of included studies</a> table). </p> <p>An update search in June 2012 identified 341 new records. The Cochrane Eyes and Vision Information Specialist scanned the search results and removed 320 records that were not relevant to the scope of the review. We screened the remaining 21 records and rejected a further 16 records as not eligible for inclusion in the review. We obtained full‐text copies of five reports of studies for further investigation. We excluded three studies: one study (<a href="https://archie.cochrane.org/sections/documents/viewDiff?documentPK=081999072209103762%26versionPK1=z1308141314194906448527178688654%26versionPK2=z1609140025183132242333806178526#STD-Kasparova-2010" target="_blank">Kasparova 2010</a>) did not include the correct patient population and two studies (<a href="https://archie.cochrane.org/sections/documents/viewDiff?documentPK=081999072209103762%26versionPK1=z1308141314194906448527178688654%26versionPK2=z1609140025183132242333806178526#STD-Yoon-2011" target="_blank">Yoon 2011</a>; <a href="https://archie.cochrane.org/sections/documents/viewDiff?documentPK=081999072209103762%26versionPK1=z1308141314194906448527178688654%26versionPK2=z1609140025183132242333806178526#STD-Ziakas-2010" target="_blank">Ziakas 2010</a>) were found not to be randomised trials (see <a href="https://archie.cochrane.org/sections/documents/viewDiff?documentPK=081999072209103762%26versionPK1=z1308141314194906448527178688654%26versionPK2=z1609140025183132242333806178526#CHARACTERISTICS_OF_EXCLUDED_STUDIES" target="_blank">Characteristics of excluded studies</a> table). The studies <a href="./references#CD001861-bbs2-0005" title="HützWW ,  StachsO ,  HengererF ,  EckhardtB . Efficacy of different excimer laser techniques in the management of recurrent corneal erosions. Ophthalmic Surgery, Lasers and Imaging2010;41(6):635‐41. ">Hutz 2010</a> and <a href="./references#CD001861-bbs2-0009" title="WongVW , ChiSC , LamDS . Diamond burr polishing for recurrent corneal erosions:results from a prospective randomized controlled trial. Cornea2009;28(2):152‐6. ">Wong 2009</a> met the inclusion criteria and were included in the review (see <a href="http://archie.cochrane.org/sections/documents/view?version=35799553068693440348120628132613%26format=REVMAN#CHARACTERISTICS_OF_INCLUDED_STUDIES" target="_blank">Characteristics of included studies</a> table). </p> <p>Updated searches conducted in December 2017 identified 836 new records (<a href="#CD001861-fig-0001">Figure 1</a>). After removing 176 duplicates, the Cochrane Information Specialist (CIS) screened the remaining 660 records and removed 616 references that were not relevant to the scope of the review. We screened the remaining 44 records and obtained two full‐text reports of studies for further assessment. We included two studies (<a href="./references#CD001861-bbs2-0001" title="AhadMA , AnadanM , TahV , DhingraS , LeylandM . Randomized controlled study of ocular lubrication versus bandage contact lens in the primary treatment of recurrent corneal erosion syndrome. Cornea2013;32(10):1311‐4. ">Ahad 2013</a>; <a href="./references#CD001861-bbs2-0002" title="ChanE , JhanjiV , ConstantinouM , AmielH , SnibsonGR , VajpayeeRB . A randomised controlled trial of alcohol delamination and phototherapeutic keratectomy for the treatment of recurrent corneal erosion syndrome. British Journal of Ophthalmology2014;98(2):166‐71. ">Chan 2014</a>) that met the inclusion criteria (see <a href="http://archie.cochrane.org/sections/documents/view?version=35799553068693440348120628132613%26format=REVMAN#CHARACTERISTICS_OF_INCLUDED_STUDIES" target="_blank">Characteristics of included studies</a>). We did not identify any ongoing studies from our searches of the clinical trials registries. </p> <div class="figure" id="CD001861-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram" data-id="CD001861-fig-0001" src="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_n/nCD001861-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> </div> </section> <section id="CD001861-sec-0047"> <h4 class="title">Included studies</h4> <p>We have given a summary of the included studies (<a href="./references#CD001861-bbs2-0001" title="AhadMA , AnadanM , TahV , DhingraS , LeylandM . Randomized controlled study of ocular lubrication versus bandage contact lens in the primary treatment of recurrent corneal erosion syndrome. Cornea2013;32(10):1311‐4. ">Ahad 2013</a>; <a href="./references#CD001861-bbs2-0002" title="ChanE , JhanjiV , ConstantinouM , AmielH , SnibsonGR , VajpayeeRB . A randomised controlled trial of alcohol delamination and phototherapeutic keratectomy for the treatment of recurrent corneal erosion syndrome. British Journal of Ophthalmology2014;98(2):166‐71. ">Chan 2014</a>; <a href="./references#CD001861-bbs2-0003" title="EkeT , MorrisonDA , AustinDJ . Recurrent symptoms following traumatic corneal abrasion: prevalence, severity, and the effect of a simple regimen of prophylaxis. Eye1999;13(Pt 3a):345‐7. ">Eke 1999</a>; <a href="./references#CD001861-bbs2-0004" title="Hope‐RossMW , ChellPB , KervickGN , McDonnellPJ , JonesHS . Oral tetracycline in the treatment of recurrent corneal erosions. Eye1994;8(Pt 4):384‐8. ">Hope‐Ross 1994</a>; <a href="./references#CD001861-bbs2-0005" title="HützWW ,  StachsO ,  HengererF ,  EckhardtB . Efficacy of different excimer laser techniques in the management of recurrent corneal erosions. Ophthalmic Surgery, Lasers and Imaging2010;41(6):635‐41. ">Hutz 2010</a>; <a href="./references#CD001861-bbs2-0006" title="HykinPG , FossAE , PavesioC , DartJK . The natural history and management of recurrent corneal erosion: a prospective randomised trial. Eye1994;8(Pt 1):35‐40. ">Hykin 1994</a>; <a href="./references#CD001861-bbs2-0007" title="OhmanL , FagerholmP . The influence of excimer laser ablation on recurrent corneal erosions: a prospective randomized study. Cornea1998;17(4):349‐52. ">Ohman 1998</a>; <a href="./references#CD001861-bbs2-0008" title="WilliamsR , BuckleyRJ . Pathogenesis and treatment of recurrent erosion. British Journal of Ophthalmology1985;69(6):435‐7. ">Williams 1985</a>; <a href="./references#CD001861-bbs2-0010" title="YamadaM , MashimaY . Three‐step treatment of recurrent corneal erosion. Folia Ophthalmologica Japonica1998;49(10):839‐43. ">Yamada 1998</a>; <a href="./references#CD001861-bbs2-0009" title="WongVW , ChiSC , LamDS . Diamond burr polishing for recurrent corneal erosions:results from a prospective randomized controlled trial. Cornea2009;28(2):152‐6. ">Wong 2009</a>) below, and have presented details in the <a href="./references#CD001861-sec-0173" title="">Characteristics of included studies</a> table and a summary in <a href="#CD001861-tbl-0004">Table 1</a>. </p> <div class="table" id="CD001861-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Included studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Treatment/ prophylaxis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Country</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>No. of participants*</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Average age</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Age range</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Percentage women</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention 1</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention 2</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Comparator</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Co‐intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Duration of treatment</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001861-bbs2-0001" title="AhadMA , AnadanM , TahV , DhingraS , LeylandM . Randomized controlled study of ocular lubrication versus bandage contact lens in the primary treatment of recurrent corneal erosion syndrome. Cornea2013;32(10):1311‐4. ">Ahad 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UK</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21‐73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Therapeutic contact lens</b> </p> <p>Air Optix Night and Day lenses (silicon hydrogel with 24% water, CIBA vision), replaced every 30 days </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Topical lubricant</b> carbomer (celluvisc) 0.5% 4 times daily and lacrilube at night </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001861-bbs2-0002" title="ChanE , JhanjiV , ConstantinouM , AmielH , SnibsonGR , VajpayeeRB . A randomised controlled trial of alcohol delamination and phototherapeutic keratectomy for the treatment of recurrent corneal erosion syndrome. British Journal of Ophthalmology2014;98(2):166‐71. ">Chan 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Australia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Phototherapeutic keratectomy</b> epithelium removed with blade, excimer laser treatment (Zyoptix, Bausch and Lomb) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Alcohol delamination</b> epithelium removed with blade, simulated excimer laser </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Stat diclofenac (Voltaren Ophthal Eye Drops), chloramphenicol 0.5% (Chlorsig, Sigma Pharmaceuticals), prednisolone phosphate 0.5% (Minims, Bausch and Lomb), postoperative chloramphenicol and fluorometholone and therapeutic contact lens paraffin based lubricating ointment at night for 3 months following treatment participants with persistent or recurring symptoms causing discomfort were offered repeat phototherapeutic keratectomy </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001861-bbs2-0003" title="EkeT , MorrisonDA , AustinDJ . Recurrent symptoms following traumatic corneal abrasion: prevalence, severity, and the effect of a simple regimen of prophylaxis. Eye1999;13(Pt 3a):345‐7. ">Eke 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prophylaxis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UK</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Topical lubrication</b> Lacrilube, Allergan at night </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>No topical lubrication</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cyclopentolate 1% drops and chloramphenicol ointment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001861-bbs2-0004" title="Hope‐RossMW , ChellPB , KervickGN , McDonnellPJ , JonesHS . Oral tetracycline in the treatment of recurrent corneal erosions. Eye1994;8(Pt 4):384‐8. ">Hope‐Ross 1994</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UK</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27‐77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>57%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral <b>oxytetracycline</b> 250 mg twice a day and topical <b>prednisolone 0.5%</b> four times a day and daily lid hygiene </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral <b>oxytetracycline</b> 250 mg twice a day and daily lid hygiene </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>No oxytetracycline or prednisolone</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Simple eye ointment. Macroerosions were treated with a single dose of cyclopentolate 1% and chloramphenicol followed by patching for 24 h and analgesia as required and paraffin (lubricating) ointment at night combined with manual debridement if the epithelium appeared wrinkled </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24 weeks for standard therapy, 12 weeks for tetracycline and 7 days for prednisolone</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001861-bbs2-0005" title="HützWW ,  StachsO ,  HengererF ,  EckhardtB . Efficacy of different excimer laser techniques in the management of recurrent corneal erosions. Ophthalmic Surgery, Lasers and Imaging2010;41(6):635‐41. ">Hutz 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Germany</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR but inclusion criteria specified &gt; 20 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR but inclusion criteria specified &gt; 20 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Transepithelial excimer laser ablation</b> </p> <p>(20 pulses of 193 nm)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Subepithelial excimer laser ablation</b> </p> <p>(20 pulses of 193 nm). Subepithelial group also received additional contact bandages postoperatively until re‐epithelialisation </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>One‐off procedure</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001861-bbs2-0006" title="HykinPG , FossAE , PavesioC , DartJK . The natural history and management of recurrent corneal erosion: a prospective randomised trial. Eye1994;8(Pt 1):35‐40. ">Hykin 1994</a> </p> <p>Prophylaxis study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prophylaxis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>UK</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>14‐80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>53%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Topical lubrication</b> paraffin ointment nightly </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> <p>hypertonic saline nightly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3‐6 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001861-bbs2-0006" title="HykinPG , FossAE , PavesioC , DartJK . The natural history and management of recurrent corneal erosion: a prospective randomised trial. Eye1994;8(Pt 1):35‐40. ">Hykin 1994</a> </p> <p>Treatment study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Anterior stromal puncture</b> </p> <p>purpose‐<br/> designed needle (Look Inc.) with a 0.1‐0.3 mm<br/> turned end. Puncture marks were made 1 mm apart to the level of Bowman's membrane over the area of affected corneal epithelium and extending for 1 mm onto normal surrounding cornea. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Therapeutic contact lens</b> </p> <p>hydrogel (80% water content) soft contact lenses, left in situ for 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If symptoms not controlled, a partial superficial keratectomy (anterior to Bowman's membrane) was performed. If this failed then the participant was withdrawn from study and total superficial keratectomy considered </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 weeks</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001861-bbs2-0007" title="OhmanL , FagerholmP . The influence of excimer laser ablation on recurrent corneal erosions: a prospective randomized study. Cornea1998;17(4):349‐52. ">Ohman 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sweden</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21‐75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Excimer laser ablation</b> (after epithelial debridement) </p> <p>Summit ExciMed 200 central ablation of 5 microns with diameter of 6.5 mm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>No excimer laser ablation</b> (epithelial debridement alone) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Epithelial debridement using a Beaver blade or a sponge. Patch overnight. Antibiotic ointment, chloramphenicol </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>One‐off procedure followed by topical treatment 3 times per day for 3‐4 days</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001861-bbs2-0008" title="WilliamsR , BuckleyRJ . Pathogenesis and treatment of recurrent erosion. British Journal of Ophthalmology1985;69(6):435‐7. ">Williams 1985</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UK</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22‐60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Therapeutic contact lens</b> hydrogel high water content lens (Duragel 75 plano) with chloramphenicol 2 times a day. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Topical lubrication</b> hypromellose drops 4 times a day and paraffin ointment (oculentum simplex) nightly </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 weeks</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001861-bbs2-0009" title="WongVW , ChiSC , LamDS . Diamond burr polishing for recurrent corneal erosions:results from a prospective randomized controlled trial. Cornea2009;28(2):152‐6. ">Wong 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20‐70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>56%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Diamond burr superficial keratectomy</b> (after epithelial debridement) </p> <p>5.0 mm diamond ball burr to polish denuded corneal surface for 30 seconds</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sham diamond burr superficial keratectomy</b> (after epithelial debridement). </p> <p>Sham procedure performed without contact of corneal surface.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Epithelial debridement: loose epithelium removed using cellulose sponge.</p> <p>Tobramycin ointment (Tobrex; Alcon) and homatropine 4% cycloplegic eyedrops were applied followed by an eye patch overnight. Postoperatively, participants received a regimen of levofloxacin 0.5% (Cravit; Santen, Osaka, Japan)<br/> for 1 week and lubricating gel (Viscotears; Novartis, Basel,<br/> Switzerland) tapered over 3–4 months </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>One‐off procedure and topical treatment over 3‐4 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001861-bbs2-0010" title="YamadaM , MashimaY . Three‐step treatment of recurrent corneal erosion. Folia Ophthalmologica Japonica1998;49(10):839‐43. ">Yamada 1998</a> prophylaxis study </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prophylaxis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Japan</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>21‐71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>35%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Antibiotic</b> </p> <p>tetracycline ointment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> <p>hypertonic saline ointment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>6 months if no subjective symptoms, 3 months if no signs</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001861-bbs2-0010" title="YamadaM , MashimaY . Three‐step treatment of recurrent corneal erosion. Folia Ophthalmologica Japonica1998;49(10):839‐43. ">Yamada 1998</a> </p> <p>treatment study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Epithelial debridement</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Anterior stromal puncture</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Therapeutic contact lens</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>NR: not reported</p> </div> </div> <section id="CD001861-sec-0048"> <h5 class="title">Design</h5> <p>Eight studies were randomised controlled trials (RCTs), seven single‐centre and one‐double centre. Two studies were quasi‐RCTs (allocation by alternation) (<a href="./references#CD001861-bbs2-0008" title="WilliamsR , BuckleyRJ . Pathogenesis and treatment of recurrent erosion. British Journal of Ophthalmology1985;69(6):435‐7. ">Williams 1985</a>; <a href="./references#CD001861-bbs2-0010" title="YamadaM , MashimaY . Three‐step treatment of recurrent corneal erosion. Folia Ophthalmologica Japonica1998;49(10):839‐43. ">Yamada 1998</a>). The studies, described below, sought to determine measures to prevent further episodes of recurrent erosion, to treat current episodes of recurrent erosion and to avert the development of recurrent erosion following a traumatic corneal erosion. We did not find any studies that compared an intervention to no treatment. We have described the interventions examined in each study briefly here and in greater detail below (see <a href="#CD001861-sec-0059">Effects of interventions</a> section). </p> </section> <section id="CD001861-sec-0049"> <h5 class="title">Participants</h5> <p>Five studies were conducted in the United Kingdom, one in Sweden, one in Germany, one in Japan, one in Hong Kong and one in Australia. The number of participants randomised ranged from 24 to 100. Male and female participants ranged in age from 14 to 80 years; one study did not include data on age and sex (<a href="./references#CD001861-bbs2-0003" title="EkeT , MorrisonDA , AustinDJ . Recurrent symptoms following traumatic corneal abrasion: prevalence, severity, and the effect of a simple regimen of prophylaxis. Eye1999;13(Pt 3a):345‐7. ">Eke 1999</a>) and we did not receive any reply to a letter written to the study authors requesting this information. Inclusion criteria differed between the studies as did the treatment regimens given prior to the trial. Details on the study populations are given below (see <a href="#CD001861-sec-0059">Effects of interventions</a> section). Nine studies included people with a diagnosis of recurrent corneal erosion and one study included people following a traumatic corneal abrasion (<a href="./references#CD001861-bbs2-0003" title="EkeT , MorrisonDA , AustinDJ . Recurrent symptoms following traumatic corneal abrasion: prevalence, severity, and the effect of a simple regimen of prophylaxis. Eye1999;13(Pt 3a):345‐7. ">Eke 1999</a>). </p> </section> </section> </section> <section id="CD001861-sec-0050"> <h3 class="title">Risk of bias in included studies</h3> <p>See <a href="#CD001861-fig-0002">Figure 2</a>; <a href="#CD001861-fig-0003">Figure 3</a> </p> <div class="figure" id="CD001861-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD001861-fig-0002" src="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_n/nCD001861-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD001861-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD001861-fig-0003" src="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_n/nCD001861-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD001861-sec-0051"> <h4 class="title">Allocation</h4> <section id="CD001861-sec-0052"> <h5 class="title">Random sequence generation</h5> <p>We assessed two studies as high risk of bias. <a href="./references#CD001861-bbs2-0008" title="WilliamsR , BuckleyRJ . Pathogenesis and treatment of recurrent erosion. British Journal of Ophthalmology1985;69(6):435‐7. ">Williams 1985</a> and <a href="./references#CD001861-bbs2-0010" title="YamadaM , MashimaY . Three‐step treatment of recurrent corneal erosion. Folia Ophthalmologica Japonica1998;49(10):839‐43. ">Yamada 1998</a> used 'alternate patients' as the randomisation method. Four studies reported an acceptable method of generating the random sequence, either random number tables (<a href="./references#CD001861-bbs2-0004" title="Hope‐RossMW , ChellPB , KervickGN , McDonnellPJ , JonesHS . Oral tetracycline in the treatment of recurrent corneal erosions. Eye1994;8(Pt 4):384‐8. ">Hope‐Ross 1994</a>) or computer‐generated (<a href="./references#CD001861-bbs2-0001" title="AhadMA , AnadanM , TahV , DhingraS , LeylandM . Randomized controlled study of ocular lubrication versus bandage contact lens in the primary treatment of recurrent corneal erosion syndrome. Cornea2013;32(10):1311‐4. ">Ahad 2013</a>; <a href="./references#CD001861-bbs2-0002" title="ChanE , JhanjiV , ConstantinouM , AmielH , SnibsonGR , VajpayeeRB . A randomised controlled trial of alcohol delamination and phototherapeutic keratectomy for the treatment of recurrent corneal erosion syndrome. British Journal of Ophthalmology2014;98(2):166‐71. ">Chan 2014</a>; <a href="./references#CD001861-bbs2-0009" title="WongVW , ChiSC , LamDS . Diamond burr polishing for recurrent corneal erosions:results from a prospective randomized controlled trial. Cornea2009;28(2):152‐6. ">Wong 2009</a>). The other studies did not specify their method of generating the random sequence but they described the participants as being randomly assigned to treatment. </p> </section> <section id="CD001861-sec-0053"> <h5 class="title">Allocation concealment</h5> <p>We assessed two studies as high risk of bias (<a href="./references#CD001861-bbs2-0008" title="WilliamsR , BuckleyRJ . Pathogenesis and treatment of recurrent erosion. British Journal of Ophthalmology1985;69(6):435‐7. ">Williams 1985</a>; <a href="./references#CD001861-bbs2-0010" title="YamadaM , MashimaY . Three‐step treatment of recurrent corneal erosion. Folia Ophthalmologica Japonica1998;49(10):839‐43. ">Yamada 1998</a>) as the investigators could foresee allocation of participants with 'alternate' allocation. Three studies reported adequate methods to conceal the allocation (<a href="./references#CD001861-bbs2-0001" title="AhadMA , AnadanM , TahV , DhingraS , LeylandM . Randomized controlled study of ocular lubrication versus bandage contact lens in the primary treatment of recurrent corneal erosion syndrome. Cornea2013;32(10):1311‐4. ">Ahad 2013</a>; <a href="./references#CD001861-bbs2-0002" title="ChanE , JhanjiV , ConstantinouM , AmielH , SnibsonGR , VajpayeeRB . A randomised controlled trial of alcohol delamination and phototherapeutic keratectomy for the treatment of recurrent corneal erosion syndrome. British Journal of Ophthalmology2014;98(2):166‐71. ">Chan 2014</a>; <a href="./references#CD001861-bbs2-0009" title="WongVW , ChiSC , LamDS . Diamond burr polishing for recurrent corneal erosions:results from a prospective randomized controlled trial. Cornea2009;28(2):152‐6. ">Wong 2009</a>) using sealed, numbered containers (<a href="./references#CD001861-bbs2-0001" title="AhadMA , AnadanM , TahV , DhingraS , LeylandM . Randomized controlled study of ocular lubrication versus bandage contact lens in the primary treatment of recurrent corneal erosion syndrome. Cornea2013;32(10):1311‐4. ">Ahad 2013</a>), independent or masked investigators, or both (<a href="./references#CD001861-bbs2-0002" title="ChanE , JhanjiV , ConstantinouM , AmielH , SnibsonGR , VajpayeeRB . A randomised controlled trial of alcohol delamination and phototherapeutic keratectomy for the treatment of recurrent corneal erosion syndrome. British Journal of Ophthalmology2014;98(2):166‐71. ">Chan 2014</a>; <a href="./references#CD001861-bbs2-0009" title="WongVW , ChiSC , LamDS . Diamond burr polishing for recurrent corneal erosions:results from a prospective randomized controlled trial. Cornea2009;28(2):152‐6. ">Wong 2009</a>). The risk of selection bias was unclear in all the other studies as insufficient information regarding allocation concealment was provided. </p> </section> </section> <section id="CD001861-sec-0054"> <h4 class="title">Blinding</h4> <section id="CD001861-sec-0055"> <h5 class="title">Blinding (masking) of participants and personnel</h5> <p>We assessed six studies as high risk of performance bias (<a href="./references#CD001861-bbs2-0001" title="AhadMA , AnadanM , TahV , DhingraS , LeylandM . Randomized controlled study of ocular lubrication versus bandage contact lens in the primary treatment of recurrent corneal erosion syndrome. Cornea2013;32(10):1311‐4. ">Ahad 2013</a>; <a href="./references#CD001861-bbs2-0002" title="ChanE , JhanjiV , ConstantinouM , AmielH , SnibsonGR , VajpayeeRB . A randomised controlled trial of alcohol delamination and phototherapeutic keratectomy for the treatment of recurrent corneal erosion syndrome. British Journal of Ophthalmology2014;98(2):166‐71. ">Chan 2014</a>; <a href="./references#CD001861-bbs2-0003" title="EkeT , MorrisonDA , AustinDJ . Recurrent symptoms following traumatic corneal abrasion: prevalence, severity, and the effect of a simple regimen of prophylaxis. Eye1999;13(Pt 3a):345‐7. ">Eke 1999</a>; <a href="./references#CD001861-bbs2-0004" title="Hope‐RossMW , ChellPB , KervickGN , McDonnellPJ , JonesHS . Oral tetracycline in the treatment of recurrent corneal erosions. Eye1994;8(Pt 4):384‐8. ">Hope‐Ross 1994</a>; <a href="./references#CD001861-bbs2-0006" title="HykinPG , FossAE , PavesioC , DartJK . The natural history and management of recurrent corneal erosion: a prospective randomised trial. Eye1994;8(Pt 1):35‐40. ">Hykin 1994</a>; <a href="./references#CD001861-bbs2-0008" title="WilliamsR , BuckleyRJ . Pathogenesis and treatment of recurrent erosion. British Journal of Ophthalmology1985;69(6):435‐7. ">Williams 1985</a>). Masking was not possible in <a href="./references#CD001861-bbs2-0003" title="EkeT , MorrisonDA , AustinDJ . Recurrent symptoms following traumatic corneal abrasion: prevalence, severity, and the effect of a simple regimen of prophylaxis. Eye1999;13(Pt 3a):345‐7. ">Eke 1999</a> and <a href="./references#CD001861-bbs2-0006" title="HykinPG , FossAE , PavesioC , DartJK . The natural history and management of recurrent corneal erosion: a prospective randomised trial. Eye1994;8(Pt 1):35‐40. ">Hykin 1994</a> when the groups were given 'ointment' versus 'drops'. Masking was not possible in <a href="./references#CD001861-bbs2-0001" title="AhadMA , AnadanM , TahV , DhingraS , LeylandM . Randomized controlled study of ocular lubrication versus bandage contact lens in the primary treatment of recurrent corneal erosion syndrome. Cornea2013;32(10):1311‐4. ">Ahad 2013</a> as therapeutic contact lens use was apparent to both participants and personnel. Masking of personnel was not possible in <a href="./references#CD001861-bbs2-0002" title="ChanE , JhanjiV , ConstantinouM , AmielH , SnibsonGR , VajpayeeRB . A randomised controlled trial of alcohol delamination and phototherapeutic keratectomy for the treatment of recurrent corneal erosion syndrome. British Journal of Ophthalmology2014;98(2):166‐71. ">Chan 2014</a> as one had to administer the phototherapeutic keratectomy. <a href="./references#CD001861-bbs2-0004" title="Hope‐RossMW , ChellPB , KervickGN , McDonnellPJ , JonesHS . Oral tetracycline in the treatment of recurrent corneal erosions. Eye1994;8(Pt 4):384‐8. ">Hope‐Ross 1994</a> and <a href="./references#CD001861-bbs2-0008" title="WilliamsR , BuckleyRJ . Pathogenesis and treatment of recurrent erosion. British Journal of Ophthalmology1985;69(6):435‐7. ">Williams 1985</a> did not perform masking. The risk of performance and detection bias was unclear in <a href="./references#CD001861-bbs2-0007" title="OhmanL , FagerholmP . The influence of excimer laser ablation on recurrent corneal erosions: a prospective randomized study. Cornea1998;17(4):349‐52. ">Ohman 1998</a> and <a href="./references#CD001861-bbs2-0010" title="YamadaM , MashimaY . Three‐step treatment of recurrent corneal erosion. Folia Ophthalmologica Japonica1998;49(10):839‐43. ">Yamada 1998</a> as the trial reports did not explicitly state if masking was performed. </p> </section> <section id="CD001861-sec-0056"> <h5 class="title">Masking of outcome assessment</h5> <p>All studies but three (<a href="./references#CD001861-bbs2-0001" title="AhadMA , AnadanM , TahV , DhingraS , LeylandM . Randomized controlled study of ocular lubrication versus bandage contact lens in the primary treatment of recurrent corneal erosion syndrome. Cornea2013;32(10):1311‐4. ">Ahad 2013</a>; <a href="./references#CD001861-bbs2-0002" title="ChanE , JhanjiV , ConstantinouM , AmielH , SnibsonGR , VajpayeeRB . A randomised controlled trial of alcohol delamination and phototherapeutic keratectomy for the treatment of recurrent corneal erosion syndrome. British Journal of Ophthalmology2014;98(2):166‐71. ">Chan 2014</a>; <a href="./references#CD001861-bbs2-0007" title="OhmanL , FagerholmP . The influence of excimer laser ablation on recurrent corneal erosions: a prospective randomized study. Cornea1998;17(4):349‐52. ">Ohman 1998</a>) had low risk of detection bias. Although the masking of outcomes was not necessarily reported in all studies, the outcomes measured were mostly self‐reported symptoms, thus unlikely to be affected by lack of masking of assessment. </p> </section> </section> <section id="CD001861-sec-0057"> <h4 class="title">Incomplete outcome data</h4> <p>We assessed two studies as high risk of attrition bias. In <a href="./references#CD001861-bbs2-0002" title="ChanE , JhanjiV , ConstantinouM , AmielH , SnibsonGR , VajpayeeRB . A randomised controlled trial of alcohol delamination and phototherapeutic keratectomy for the treatment of recurrent corneal erosion syndrome. British Journal of Ophthalmology2014;98(2):166‐71. ">Chan 2014</a> there was high loss to follow‐up at 24 months and follow‐up was unequal between groups. In <a href="./references#CD001861-bbs2-0010" title="YamadaM , MashimaY . Three‐step treatment of recurrent corneal erosion. Folia Ophthalmologica Japonica1998;49(10):839‐43. ">Yamada 1998</a> there was unequal follow‐up between groups. Two studies (<a href="./references#CD001861-bbs2-0003" title="EkeT , MorrisonDA , AustinDJ . Recurrent symptoms following traumatic corneal abrasion: prevalence, severity, and the effect of a simple regimen of prophylaxis. Eye1999;13(Pt 3a):345‐7. ">Eke 1999</a>; <a href="./references#CD001861-bbs2-0006" title="HykinPG , FossAE , PavesioC , DartJK . The natural history and management of recurrent corneal erosion: a prospective randomised trial. Eye1994;8(Pt 1):35‐40. ">Hykin 1994</a>) had an unclear risk of attrition bias as insufficent data were provided regarding loss to follow‐up. All other studies were judged to be of low risk of attrition bias as all enrolled participants were accounted for. </p> </section> <section id="CD001861-sec-0058"> <h4 class="title">Selective reporting</h4> <p>All but one study had low risk of bias. <a href="./references#CD001861-bbs2-0005" title="HützWW ,  StachsO ,  HengererF ,  EckhardtB . Efficacy of different excimer laser techniques in the management of recurrent corneal erosions. Ophthalmic Surgery, Lasers and Imaging2010;41(6):635‐41. ">Hutz 2010</a> did not report patient symptoms post‐treatment. Patient symptoms are a major outcome measure for the management of recurrent corneal erosions. </p> </section> </section> <section id="CD001861-sec-0059"> <h3 class="title" id="CD001861-sec-0059">Effects of interventions</h3> <p>See: <a href="./full#CD001861-tbl-0001"><b>Summary of findings for the main comparison</b> Therapeutic contact lens versus topical lubrication for the treatment of recurrent corneal erosion syndrome</a>; <a href="./full#CD001861-tbl-0002"><b>Summary of findings 2</b> Phototherapeutic keratectomy versus alcohol delamination for the treatment of recurrent corneal erosion syndrome</a>; <a href="./full#CD001861-tbl-0003"><b>Summary of findings 3</b> Diamond burr superficial keratectomy (after epithelial debridement) versus sham diamond burr (after epithelial debridement) for the treatment of recurrent corneal erosion syndrome</a> </p> <section id="CD001861-sec-0060"> <h4 class="title">Treatment of recurrent corneal erosion syndrome</h4> <p>We have covered the following eight comparisons in this section and we have prepared 'Summary of findings' tables and assessed the three most clinically relevant comparisons using GRADE. </p> <p> <ol id="CD001861-list-0010"> <li> <p>Therapeutic contact lens versus topical lubrication (<a href="./references#CD001861-bbs2-0001" title="AhadMA , AnadanM , TahV , DhingraS , LeylandM . Randomized controlled study of ocular lubrication versus bandage contact lens in the primary treatment of recurrent corneal erosion syndrome. Cornea2013;32(10):1311‐4. ">Ahad 2013</a>; <a href="./references#CD001861-bbs2-0008" title="WilliamsR , BuckleyRJ . Pathogenesis and treatment of recurrent erosion. British Journal of Ophthalmology1985;69(6):435‐7. ">Williams 1985;</a><a href="./full#CD001861-tbl-0001">summary of findings Table for the main comparison</a>) </p> </li> <li> <p>Phototherapeutic keratectomy (after epithelial debridement) versus alcohol delamination and sham excimer laser (after epithelial debridement) (<a href="./references#CD001861-bbs2-0002" title="ChanE , JhanjiV , ConstantinouM , AmielH , SnibsonGR , VajpayeeRB . A randomised controlled trial of alcohol delamination and phototherapeutic keratectomy for the treatment of recurrent corneal erosion syndrome. British Journal of Ophthalmology2014;98(2):166‐71. ">Chan 2014</a>; <a href="./full#CD001861-tbl-0002">summary of findings Table 2</a>) </p> </li> <li> <p>Diamond burr superficial keratectomy (after epithelial debridement) versus sham diamond burr (after epithelial debridement) (<a href="./references#CD001861-bbs2-0009" title="WongVW , ChiSC , LamDS . Diamond burr polishing for recurrent corneal erosions:results from a prospective randomized controlled trial. Cornea2009;28(2):152‐6. ">Wong 2009</a>; <a href="./full#CD001861-tbl-0003">summary of findings Table 3</a>) </p> </li> <li> <p>Transepithelial versus subepithelial excimer laser ablation (<a href="./references#CD001861-bbs2-0005" title="HützWW ,  StachsO ,  HengererF ,  EckhardtB . Efficacy of different excimer laser techniques in the management of recurrent corneal erosions. Ophthalmic Surgery, Lasers and Imaging2010;41(6):635‐41. ">Hutz 2010</a>) </p> </li> <li> <p>Excimer laser ablation (after epithelial debridement) versus no excimer laser ablation (after epithelial debridement) (<a href="./references#CD001861-bbs2-0007" title="OhmanL , FagerholmP . The influence of excimer laser ablation on recurrent corneal erosions: a prospective randomized study. Cornea1998;17(4):349‐52. ">Ohman 1998</a>) </p> </li> <li> <p>Epithelial debridement versus anterior stromal puncture (<a href="./references#CD001861-bbs2-0010" title="YamadaM , MashimaY . Three‐step treatment of recurrent corneal erosion. Folia Ophthalmologica Japonica1998;49(10):839‐43. ">Yamada 1998</a>) </p> </li> <li> <p>Anterior stromal puncture versus therapeutic contact lens (<a href="./references#CD001861-bbs2-0006" title="HykinPG , FossAE , PavesioC , DartJK . The natural history and management of recurrent corneal erosion: a prospective randomised trial. Eye1994;8(Pt 1):35‐40. ">Hykin 1994</a>) </p> </li> <li> <p>Oral oxytetracycline and topical prednisolone (in addition to 'standard therapy') versus oral oxytetracycline (in addition to 'standard therapy') versus 'standard therapy' (<a href="./references#CD001861-bbs2-0004" title="Hope‐RossMW , ChellPB , KervickGN , McDonnellPJ , JonesHS . Oral tetracycline in the treatment of recurrent corneal erosions. Eye1994;8(Pt 4):384‐8. ">Hope‐Ross 1994</a>) </p> </li> </ol> </p> <section id="CD001861-sec-0061"> <h5 class="title">1. Therapeutic contact lens versus topical lubrication</h5> <p><a href="./full#CD001861-tbl-0001">summary of findings Table for the main comparison</a> </p> <p>Two studies addressed this comparison. <a href="./references#CD001861-bbs2-0008" title="WilliamsR , BuckleyRJ . Pathogenesis and treatment of recurrent erosion. British Journal of Ophthalmology1985;69(6):435‐7. ">Williams 1985</a> included 31 participants with recurrent corneal erosion from map‐dot‐fingerprint (epithelial basement membrane) dystrophy who had received no previous treatment other than topical therapy, presenting to the Casualty Department, Moorfields Eye Hospital, United Kingdom. Participants were excluded if they wore contact lenses. <a href="./references#CD001861-bbs2-0001" title="AhadMA , AnadanM , TahV , DhingraS , LeylandM . Randomized controlled study of ocular lubrication versus bandage contact lens in the primary treatment of recurrent corneal erosion syndrome. Cornea2013;32(10):1311‐4. ">Ahad 2013</a> included 29 participants with recurrent corneal erosions and who had not "undergone any treatment other than lubricants or antibiotics…in previous episodes". Participants were recruited from the Royal Berkshire Hospital and Oxford Eye Hospital, UK. Exclusion criteria included ocular surface disease, refractive surgery and history of corneal infection or surgery. </p> <p>In <a href="./references#CD001861-bbs2-0001" title="AhadMA , AnadanM , TahV , DhingraS , LeylandM . Randomized controlled study of ocular lubrication versus bandage contact lens in the primary treatment of recurrent corneal erosion syndrome. Cornea2013;32(10):1311‐4. ">Ahad 2013</a> the therapeutic contact lens was Air Optix Night and Day (CIBA Vision) and they compared this to topical lubrication with Celluvisc and Lacri‐Lube ointment. Co‐intervention with chloramphenicol eye drops was given to all participants with macroerosions or epithelial defects. <a href="./references#CD001861-bbs2-0008" title="WilliamsR , BuckleyRJ . Pathogenesis and treatment of recurrent erosion. British Journal of Ophthalmology1985;69(6):435‐7. ">Williams 1985</a> compared a 14 mm Duragel 75 therapeutic contact lens (high water‐content hydrogel lens) with hypromellose drops and paraffin ointment at night. This contact lens type has since been superseded for therapeutic use by newer lens designs (such as silicone hydrogel lens and collagen shields). </p> <section id="CD001861-sec-0062"> <h6 class="title">Resolution of symptoms after treatment</h6> <p><a href="./references#CD001861-bbs2-0001" title="AhadMA , AnadanM , TahV , DhingraS , LeylandM . Randomized controlled study of ocular lubrication versus bandage contact lens in the primary treatment of recurrent corneal erosion syndrome. Cornea2013;32(10):1311‐4. ">Ahad 2013</a> found a comparable proportion of participants achieved complete resolution after treatment between the therapeutic contact lens (10/14) and topical lubrication (11/15) groups at four months (RR 0.97, 95% confidence interval (CI) 0.62 to 1.53; <a href="./references#CD001861-fig-0004" title="">Analysis 1.1</a>). ‘Resolution’ included both subjective symptom reporting and objective slit‐lamp ocular findings. <a href="./references#CD001861-bbs2-0008" title="WilliamsR , BuckleyRJ . Pathogenesis and treatment of recurrent erosion. British Journal of Ophthalmology1985;69(6):435‐7. ">Williams 1985</a> did not report this outcome. We judged this low‐certainty evidence, downgrading for imprecision and risk of bias. </p> </section> <section id="CD001861-sec-0063"> <h6 class="title">Total number of erosions after treatment</h6> <p>Neither study reported this outcome.</p> </section> <section id="CD001861-sec-0064"> <h6 class="title">Time to resolution of symptoms</h6> <p><a href="./references#CD001861-bbs2-0001" title="AhadMA , AnadanM , TahV , DhingraS , LeylandM . Randomized controlled study of ocular lubrication versus bandage contact lens in the primary treatment of recurrent corneal erosion syndrome. Cornea2013;32(10):1311‐4. ">Ahad 2013</a> reported a faster time to resolution in the therapeutic contact lens group versus the topical lubrication group (5 weeks versus 9 weeks, P = 0.02). </p> </section> <section id="CD001861-sec-0065"> <h6 class="title">Recurrences after complete or partial resolution</h6> <p><a href="./references#CD001861-bbs2-0001" title="AhadMA , AnadanM , TahV , DhingraS , LeylandM . Randomized controlled study of ocular lubrication versus bandage contact lens in the primary treatment of recurrent corneal erosion syndrome. Cornea2013;32(10):1311‐4. ">Ahad 2013</a> reported that one participant (7.1%) in the contact lens group and one participant (6.7%) in the topical lubrication group developed recurrence after complete or partial resolution at seven‐month follow‐up (RR 1.07, 95% CI 0.07 to 15.54; <a href="./references#CD001861-fig-0004" title="">Analysis 1.1</a>). <a href="./references#CD001861-bbs2-0008" title="WilliamsR , BuckleyRJ . Pathogenesis and treatment of recurrent erosion. British Journal of Ophthalmology1985;69(6):435‐7. ">Williams 1985</a> did not report this outcome. We judged this very low‐certainty evidence downgrading one level for limitations in design due to study personnel not being masked and downgrading two levels for imprecision due to the small number of events. </p> </section> <section id="CD001861-sec-0066"> <h6 class="title">Time to recurrence</h6> <p>Neither study reported this outcome.</p> </section> <section id="CD001861-sec-0067"> <h6 class="title">Recurrences requiring further treatment</h6> <p><a href="./references#CD001861-bbs2-0001" title="AhadMA , AnadanM , TahV , DhingraS , LeylandM . Randomized controlled study of ocular lubrication versus bandage contact lens in the primary treatment of recurrent corneal erosion syndrome. Cornea2013;32(10):1311‐4. ">Ahad 2013</a> did not state explicitly whether participants with recurrences after complete resolution (one per group) required further treatment although they stated they were minor symptoms of recurrent corneal erosions with no obvious macroerosions. <a href="./references#CD001861-bbs2-0008" title="WilliamsR , BuckleyRJ . Pathogenesis and treatment of recurrent erosion. British Journal of Ophthalmology1985;69(6):435‐7. ">Williams 1985</a> did not report this outcome. </p> </section> <section id="CD001861-sec-0068"> <h6 class="title">Symptoms (pain score)</h6> <p><a href="./references#CD001861-bbs2-0001" title="AhadMA , AnadanM , TahV , DhingraS , LeylandM . Randomized controlled study of ocular lubrication versus bandage contact lens in the primary treatment of recurrent corneal erosion syndrome. Cornea2013;32(10):1311‐4. ">Ahad 2013</a> used a visual analogue scale to grade pain postintervention at one month intervals for three months. The study reported no difference in pain scores between the groups at all measured time intervals but did not provide standard deviations or details regarding the pain scale. At three months, people in the therapeutic contact lens group had an average reported pain score of 3 and people in the topical lubrication group of 2. <a href="./references#CD001861-bbs2-0008" title="WilliamsR , BuckleyRJ . Pathogenesis and treatment of recurrent erosion. British Journal of Ophthalmology1985;69(6):435‐7. ">Williams 1985</a> reported that more participants in the therapeutic contact lens group (8/11) had pain symptoms compared to the topical lubrication group (3/13) at eight weeks' follow‐up (RR 3.15, 95% CI 1.10 to 9.06; <a href="./references#CD001861-fig-0006" title="">Analysis 1.3</a>). This evidence is of low certainty, downgraded for limitation in design due to lack of masking and imprecision due to small sample size. </p> </section> <section id="CD001861-sec-0069"> <h6 class="title">Adverse effects (corneal haze, astigmatism)</h6> <p><a href="./references#CD001861-bbs2-0001" title="AhadMA , AnadanM , TahV , DhingraS , LeylandM . Randomized controlled study of ocular lubrication versus bandage contact lens in the primary treatment of recurrent corneal erosion syndrome. Cornea2013;32(10):1311‐4. ">Ahad 2013</a> reported that, "none of the participants in the therapeutic contact lens group developed any complications". Development of any adverse effects in the topical lubrication group was not stated explicitly. <a href="./references#CD001861-bbs2-0008" title="WilliamsR , BuckleyRJ . Pathogenesis and treatment of recurrent erosion. British Journal of Ophthalmology1985;69(6):435‐7. ">Williams 1985</a> reported a significantly higher rate of ocular complications in the therapeutic contact lens group compared to the topical lubrication group. In the contact lens group, three participants had extensive epithelial loss under the contact lens (two of these participants abandoned the lens); this complication is associated with the type of contact lens used and is not seen in newer lenses with higher oxygen transmission. Contact lens treatment failed in four participants as they frequently lost the lens and it had to be replaced. </p> </section> </section> <section id="CD001861-sec-0070"> <h5 class="title">2. Phototherapeutic keratectomy (after epithelial debridement) versus alcohol delamination and sham excimer laser (after epithelial debridement) </h5> <p><a href="./full#CD001861-tbl-0002">summary of findings Table 2</a> </p> <p><a href="./references#CD001861-bbs2-0002" title="ChanE , JhanjiV , ConstantinouM , AmielH , SnibsonGR , VajpayeeRB . A randomised controlled trial of alcohol delamination and phototherapeutic keratectomy for the treatment of recurrent corneal erosion syndrome. British Journal of Ophthalmology2014;98(2):166‐71. ">Chan 2014</a> recruited 33 participants presenting with symptomatic recurrent corneal erosions not responding to conservative treatment (topical lubricants and a therapeutic contact lens) at the Royal Victorian Eye and Ear Hospital, Melbourne Australia. Participants were excluded if they had had previous ocular surgery, prior treatment for recurrent corneal erosion other than manual epithelial debridement, a history of corneal or external eye disorders, corneal hypoaesthesia or diabetes mellitus. </p> <p>The study compared phototherapeutic keratectomy (excimer laser ablation) versus alcohol delamination. Postoperatively diclofenac, chloramphenicol, prednisolone, therapeutic contact lens and paraffin based lubricating ointment were given to all participants. </p> <section id="CD001861-sec-0071"> <h6 class="title">Resolution of symptoms after treatment</h6> <p><a href="./references#CD001861-bbs2-0002" title="ChanE , JhanjiV , ConstantinouM , AmielH , SnibsonGR , VajpayeeRB . A randomised controlled trial of alcohol delamination and phototherapeutic keratectomy for the treatment of recurrent corneal erosion syndrome. British Journal of Ophthalmology2014;98(2):166‐71. ">Chan 2014</a> reported complete resolution of symptoms in six of 16 of the phototherapeutic keratopathy group and 10 of 17 participants receiving alcohol delamination (RR 0.64, 95% CI 0.30 to 1.35; <a href="./references#CD001861-fig-0007" title="">Analysis 2.1</a>). ‘Improvement’ was judged symptomatically without ocular findings stated explicitly. We judged this to be low‐certainty evidence, downgrading for risk of bias and imprecision. </p> </section> <section id="CD001861-sec-0072"> <h6 class="title">Total number of erosions after treatment</h6> <p><a href="./references#CD001861-bbs2-0002" title="ChanE , JhanjiV , ConstantinouM , AmielH , SnibsonGR , VajpayeeRB . A randomised controlled trial of alcohol delamination and phototherapeutic keratectomy for the treatment of recurrent corneal erosion syndrome. British Journal of Ophthalmology2014;98(2):166‐71. ">Chan 2014</a> did not explicitly report the total number of erosions after treatment. </p> </section> <section id="CD001861-sec-0073"> <h6 class="title">Time to resolution of symptoms</h6> <p><a href="./references#CD001861-bbs2-0002" title="ChanE , JhanjiV , ConstantinouM , AmielH , SnibsonGR , VajpayeeRB . A randomised controlled trial of alcohol delamination and phototherapeutic keratectomy for the treatment of recurrent corneal erosion syndrome. British Journal of Ophthalmology2014;98(2):166‐71. ">Chan 2014</a> did not report the time to resolution of symptoms. </p> </section> <section id="CD001861-sec-0074"> <h6 class="title">Recurrences after complete or partial resolution</h6> <p>Six participants (37.5%) in the phototherapeutic keratectomy group and five participants (29.4%) in the alcohol delamination group developed recurrence after complete or partial resolution at 24‐month follow‐up. This finding was not statistically significant (RR 1.27, 95% CI 0.48 to 3.37; <a href="./references#CD001861-fig-0008" title="">Analysis 2.2</a>) and is of low certainty given limitations in design due to lack of masking and imprecision due to small sample size. </p> </section> <section id="CD001861-sec-0075"> <h6 class="title">Time to recurrence</h6> <p><a href="./references#CD001861-bbs2-0002" title="ChanE , JhanjiV , ConstantinouM , AmielH , SnibsonGR , VajpayeeRB . A randomised controlled trial of alcohol delamination and phototherapeutic keratectomy for the treatment of recurrent corneal erosion syndrome. British Journal of Ophthalmology2014;98(2):166‐71. ">Chan 2014</a> reported a similar time to recurrence after complete or partial resolution of 6.5 months (range 3 to 12 months) and 6 months (range 3 to 12 months) in the phototherapeutic keratectomy and alcohol delamination groups respectively. This difference was not statistically significant (P = 0.85). The evidence is of low certainty given limitations in design due to lack of masking and imprecision due to small sample size. </p> </section> <section id="CD001861-sec-0076"> <h6 class="title">Recurrences requiring further treatment</h6> <p><a href="./references#CD001861-bbs2-0002" title="ChanE , JhanjiV , ConstantinouM , AmielH , SnibsonGR , VajpayeeRB . A randomised controlled trial of alcohol delamination and phototherapeutic keratectomy for the treatment of recurrent corneal erosion syndrome. British Journal of Ophthalmology2014;98(2):166‐71. ">Chan 2014</a> reported that two participants with recurrence in the phototherapeutic keratectomy group underwent repeat phototherapeutic keratectomy that achieved resolution. In the alcohol delamination group, three people with recurrence subsequently underwent phototherapeutic keratectomy, of whom one was lost to follow‐up, one had symptom improvement and one had symptom resolution. This finding was of very low certainty given limitations in design due to lack of masking and imprecision due to very small numbers (RR 0.71, 95% 0.14 to 3.70; <a href="./references#CD001861-fig-0010" title="">Analysis 2.4</a>). </p> </section> <section id="CD001861-sec-0077"> <h6 class="title">Symptoms (pain score)</h6> <p><a href="./references#CD001861-bbs2-0002" title="ChanE , JhanjiV , ConstantinouM , AmielH , SnibsonGR , VajpayeeRB . A randomised controlled trial of alcohol delamination and phototherapeutic keratectomy for the treatment of recurrent corneal erosion syndrome. British Journal of Ophthalmology2014;98(2):166‐71. ">Chan 2014</a> scored pain using a numerical scale and demonstrated lower pain scores (less pain) in the phototherapeutic keratectomy group compared to the alcohol delamination group at 24‐month follow‐up (MD ‐0.7, 95% CI ‐2.23 to 0.83; <a href="./references#CD001861-fig-0009" title="">Analysis 2.3</a>). The evidence is of low certainty given limitations in design due to lack of masking and imprecision due to small sample size. </p> </section> <section id="CD001861-sec-0078"> <h6 class="title">Adverse effects (corneal haze, astigmatism)</h6> <p><a href="./references#CD001861-bbs2-0002" title="ChanE , JhanjiV , ConstantinouM , AmielH , SnibsonGR , VajpayeeRB . A randomised controlled trial of alcohol delamination and phototherapeutic keratectomy for the treatment of recurrent corneal erosion syndrome. British Journal of Ophthalmology2014;98(2):166‐71. ">Chan 2014</a> reported no cases of corneal haze at the 12‐month time point in either group. The evidence is of very low certainty given limitations in design due to lack of masking and imprecision due to a small sample size where event rate could not be estimated. </p> </section> </section> <section id="CD001861-sec-0079"> <h5 class="title">3. Diamond burr superficial keratectomy (after epithelial debridement) versus sham diamond burr (after epithelial debridement) </h5> <p><a href="./full#CD001861-tbl-0003">summary of findings Table 3</a> </p> <p><a href="./references#CD001861-bbs2-0009" title="WongVW , ChiSC , LamDS . Diamond burr polishing for recurrent corneal erosions:results from a prospective randomized controlled trial. Cornea2009;28(2):152‐6. ">Wong 2009</a> recruited 48 participants from Hong Kong Eye Hospital who had recurrent corneal erosions secondary to trauma or anterior basement membrane dystrophy with more than one episode of corneal erosion within the past month, or with symptoms affecting activities of daily living. Participants with corneal dystrophies other than anterior basement membrane dystrophy were excluded. </p> <p>All participants had epithelial debridement whereby loose epithelium was removed using a cellulose sponge. In the diamond burr group, the denuded area was "gently and evenly polished" with a diamond burr with a 5.0 mm ball. In the comparator group, the diamond burr was switched on but did not touch the cornea. All participants received levofloxacin 0.5% for one week and topical lubrication (Viscotears) tapered over three to four months. </p> <section id="CD001861-sec-0080"> <h6 class="title">Resolution of symptoms after treatment</h6> <p><a href="./references#CD001861-bbs2-0009" title="WongVW , ChiSC , LamDS . Diamond burr polishing for recurrent corneal erosions:results from a prospective randomized controlled trial. Cornea2009;28(2):152‐6. ">Wong 2009</a> did not report this outcome. </p> </section> <section id="CD001861-sec-0081"> <h6 class="title">Total number of erosions after treatment</h6> <p><a href="./references#CD001861-bbs2-0009" title="WongVW , ChiSC , LamDS . Diamond burr polishing for recurrent corneal erosions:results from a prospective randomized controlled trial. Cornea2009;28(2):152‐6. ">Wong 2009</a> did not report this outcome. </p> </section> <section id="CD001861-sec-0082"> <h6 class="title">Time to resolution of symptoms</h6> <p><a href="./references#CD001861-bbs2-0009" title="WongVW , ChiSC , LamDS . Diamond burr polishing for recurrent corneal erosions:results from a prospective randomized controlled trial. Cornea2009;28(2):152‐6. ">Wong 2009</a> did not report this outcome. </p> </section> <section id="CD001861-sec-0083"> <h6 class="title">Recurrences after complete or partial resolution</h6> <p>One participant (4%) in the diamond burr superficial keratectomy group and 13 participants (56.6%) in the sham diamond burr group developed recurrence after complete or partial resolution at six‐month follow‐up. This finding suggests recurrences were less common in the diamond burr superficial keratectomy group (RR 0.07, 95% CI 0.01 to 0.50; <a href="./references#CD001861-fig-0011" title="">Analysis 3.1</a>). This evidence is of moderate certainty, downgraded for imprecision as it is based on small numbers (one event in the intervention group). </p> </section> <section id="CD001861-sec-0084"> <h6 class="title">Time to recurrence</h6> <p><a href="./references#CD001861-bbs2-0009" title="WongVW , ChiSC , LamDS . Diamond burr polishing for recurrent corneal erosions:results from a prospective randomized controlled trial. Cornea2009;28(2):152‐6. ">Wong 2009</a> reported that time to recurrence was prolonged in the diamond burr superficial keratectomy group compared to the sham diamond burr group (6.0 versus 2.4 months, 95% CI not provided). This result was of low certainty given imprecision from a small sample size (only one recurrence in the diamond burr group). </p> </section> <section id="CD001861-sec-0085"> <h6 class="title">Recurrences requiring further treatment</h6> <p><a href="./references#CD001861-bbs2-0009" title="WongVW , ChiSC , LamDS . Diamond burr polishing for recurrent corneal erosions:results from a prospective randomized controlled trial. Cornea2009;28(2):152‐6. ">Wong 2009</a> did not report the number of recurrences requiring further treatment. </p> </section> <section id="CD001861-sec-0086"> <h6 class="title">Symptoms (pain score)</h6> <p>The study authors did not report pain symptoms in the participants.</p> <p><a href="./references#CD001861-bbs2-0009" title="WongVW , ChiSC , LamDS . Diamond burr polishing for recurrent corneal erosions:results from a prospective randomized controlled trial. Cornea2009;28(2):152‐6. ">Wong 2009</a> reported lesser minor symptom recurrence (self‐limiting, not requiring ophthalmological consultation) in the diamond burr‐polishing group compared with sham diamond burr group at six months' follow‐up (20% versus 65%). Major symptoms requiring ophthalmological consultation occurred more commonly in the epithelial debridement group compared to the diamond burr‐polishing group (57% versus 4%). </p> </section> <section id="CD001861-sec-0087"> <h6 class="title">Adverse effects (corneal haze, astigmatism)</h6> <p><a href="./references#CD001861-bbs2-0009" title="WongVW , ChiSC , LamDS . Diamond burr polishing for recurrent corneal erosions:results from a prospective randomized controlled trial. Cornea2009;28(2):152‐6. ">Wong 2009</a> reported one participant with corneal haze at six months in each of the diamond burr superficial keratectomy (4%) and sham diamond burr group (4.3%) (RR 0.92, 95% CI 0.06 to 13.87; <a href="./references#CD001861-fig-0012" title="">Analysis 3.2</a>) and was of low certainty given imprecision due to small sample size and wide confidence interval. </p> <p>The mean astigmatism was 0.44 and 0.88 dioptres in the diamond burr superficial keratectomy and sham diamond burr groups respectively. We could not estimate the significance and the finding is of moderate certainty given imprecision due to small sample size. </p> </section> </section> <section id="CD001861-sec-0088"> <h5 class="title">4. Transepithelial versus subepithelial excimer laser ablation</h5> <p><a href="./references#CD001861-bbs2-0005" title="HützWW ,  StachsO ,  HengererF ,  EckhardtB . Efficacy of different excimer laser techniques in the management of recurrent corneal erosions. Ophthalmic Surgery, Lasers and Imaging2010;41(6):635‐41. ">Hutz 2010</a> included 100 participants with recurrent corneal erosions occurring "at least three times per year" and with the first occurrence of the erosion being of "traumatic origin". Participants were recruited from several centres in Germany by "transferring physicians". The study was conducted in one location. </p> <p>Transepithelial versus subepithelial technique of excimer laser ablation (20 pulses of 193 nm). Ofloxacin was given to both groups postoperatively but only the subepithelial group had their eyelids closed "underneath bandages" until re‐epithelialisation. None of the participants received steroid eye drops during the study (<a href="./references#CD001861-bbs2-0005" title="HützWW ,  StachsO ,  HengererF ,  EckhardtB . Efficacy of different excimer laser techniques in the management of recurrent corneal erosions. Ophthalmic Surgery, Lasers and Imaging2010;41(6):635‐41. ">Hutz 2010</a>). </p> <section id="CD001861-sec-0089"> <h6 class="title">Resolution of symptoms after treatment</h6> <p>This outcome was not reported.</p> </section> <section id="CD001861-sec-0090"> <h6 class="title">Total number of erosions after treatment</h6> <p>This outcome was not reported.</p> </section> <section id="CD001861-sec-0091"> <h6 class="title">Time to resolution of symptoms</h6> <p>This outcome was not reported.</p> </section> <section id="CD001861-sec-0092"> <h6 class="title">Recurrences after complete or partial resolution</h6> <p>This outcome was not reported.</p> </section> <section id="CD001861-sec-0093"> <h6 class="title">Time to recurrence</h6> <p>This outcome was not reported.</p> </section> <section id="CD001861-sec-0094"> <h6 class="title">Recurrences requiring further treatment</h6> <p><a href="./references#CD001861-bbs2-0005" title="HützWW ,  StachsO ,  HengererF ,  EckhardtB . Efficacy of different excimer laser techniques in the management of recurrent corneal erosions. Ophthalmic Surgery, Lasers and Imaging2010;41(6):635‐41. ">Hutz 2010</a> had seven of 50 participants with recurrent corneal erosion in both groups at four‐week follow‐up after excimer laser ablation. These participants were excluded from follow‐up at 52 weeks. At 52‐week follow‐up, 12 of 43 and 10 of 43 participants developed recurrent corneal erosions in the transepithelial and subepithelial groups, respectively (RR 1.20, 95% CI 0.58 to 2.48; <a href="./references#CD001861-fig-0013" title="">Analysis 4.1</a>). It was stated that the recurrences were "subsequently treated". </p> </section> <section id="CD001861-sec-0095"> <h6 class="title">Symptoms (pain score)</h6> <p><a href="./references#CD001861-bbs2-0005" title="HützWW ,  StachsO ,  HengererF ,  EckhardtB . Efficacy of different excimer laser techniques in the management of recurrent corneal erosions. Ophthalmic Surgery, Lasers and Imaging2010;41(6):635‐41. ">Hutz 2010</a> reported only risks of occurrence of recurrent corneal erosions, which were similar in both groups (24% versus 20% at 52 weeks). Symptoms were not explicitly stated. </p> </section> <section id="CD001861-sec-0096"> <h6 class="title">Adverse effects</h6> <p>This outcome was not reported.</p> </section> </section> <section id="CD001861-sec-0097"> <h5 class="title">5. Excimer laser (after epithelial debridement) versus no excimer laser (after epithelial debridement) </h5> <p><a href="./references#CD001861-bbs2-0007" title="OhmanL , FagerholmP . The influence of excimer laser ablation on recurrent corneal erosions: a prospective randomized study. Cornea1998;17(4):349‐52. ">Ohman 1998</a> included 56 participants from St Erik Eye Hospital, Stockholm, Sweden who had had symptoms of recurrent corneal erosion for longer than three months, some of whom had already been treated with ointment and patching and in some cases manual debridement. </p> <p>The study compared epithelial debridement followed by excimer laser and an eye patch overnight versus epithelial debridement and an eye patch overnight alone. </p> <section id="CD001861-sec-0098"> <h6 class="title">Resolution of symptoms after treatment</h6> <p><a href="./references#CD001861-bbs2-0007" title="OhmanL , FagerholmP . The influence of excimer laser ablation on recurrent corneal erosions: a prospective randomized study. Cornea1998;17(4):349‐52. ">Ohman 1998</a> did not explicitly report resolution of symptoms after treatment. </p> </section> <section id="CD001861-sec-0099"> <h6 class="title">Total number of erosions after treatment</h6> <p>This outcome was not reported.</p> </section> <section id="CD001861-sec-0100"> <h6 class="title">Time to resolution of symptoms</h6> <p>This outcome was not reported.</p> </section> <section id="CD001861-sec-0101"> <h6 class="title">Recurrences after complete or partial resolution</h6> <p><a href="./references#CD001861-bbs2-0007" title="OhmanL , FagerholmP . The influence of excimer laser ablation on recurrent corneal erosions: a prospective randomized study. Cornea1998;17(4):349‐52. ">Ohman 1998</a> found two erosion recurrences in 28 participants in the excimer laser ablation plus debridement group compared to 16 in 28 participants in the debridement‐alone group (RR 0.13, 95% CI 0.03 to 0.51). Of the 16 participants in the control group with recurrence, three did not want treatment and 13 accepted treatment with excimer laser ablation. </p> </section> <section id="CD001861-sec-0102"> <h6 class="title">Time to recurrence</h6> <p>This outcome was not reported.</p> </section> <section id="CD001861-sec-0103"> <h6 class="title">Recurrences requiring further treatment</h6> <p><a href="./references#CD001861-bbs2-0007" title="OhmanL , FagerholmP . The influence of excimer laser ablation on recurrent corneal erosions: a prospective randomized study. Cornea1998;17(4):349‐52. ">Ohman 1998</a> had 2 of 25 (8%) participants with recurrent corneal erosion after excimer laser ablation; these participants did not receive further treatment as their remaining symptoms were acceptable. After epithelial debridement alone, 16 of 26 (62%) participants had recurrent erosions; of these, three did not want treatment and 13 accepted treatment with laser ablation (RR 0.13, 95% CI 0.03 to 0.51; <a href="./references#CD001861-fig-0014" title="">Analysis 5.1</a>). </p> </section> <section id="CD001861-sec-0104"> <h6 class="title">Symptoms (pain score)</h6> <p><a href="./references#CD001861-bbs2-0007" title="OhmanL , FagerholmP . The influence of excimer laser ablation on recurrent corneal erosions: a prospective randomized study. Cornea1998;17(4):349‐52. ">Ohman 1998</a> reported that 24 of 26 (92%) of participants given epithelial debridement followed by excimer laser had much improved or no symptoms compared with 9 of 25 (36%) of participants given epithelial debridement alone (RR 2.56, 95% CI 1.50 to 4.38; <a href="./references#CD001861-fig-0015" title="">Analysis 5.2</a>). </p> </section> <section id="CD001861-sec-0105"> <h6 class="title">Adverse effects</h6> <p><a href="./references#CD001861-bbs2-0007" title="OhmanL , FagerholmP . The influence of excimer laser ablation on recurrent corneal erosions: a prospective randomized study. Cornea1998;17(4):349‐52. ">Ohman 1998</a> stated that there was no change in their adverse effect outcomes (visual acuity, intraocular pressure and refraction) though slight subepithelial haze was seen in treatment and control groups at three and six months but not afterwards. </p> </section> </section> <section id="CD001861-sec-0106"> <h5 class="title">6. Epithelial debridement versus anterior stromal puncture</h5> <p><a href="./references#CD001861-bbs2-0010" title="YamadaM , MashimaY . Three‐step treatment of recurrent corneal erosion. Folia Ophthalmologica Japonica1998;49(10):839‐43. ">Yamada 1998</a> fitted a therapeutic contact lens for people whose prophylactic regimen had failed, and if this was not successful, the participants were to be randomised into a treatment arm. Participants were recruited from a single centre in Japan. Three participants (two using hypertonic saline and one using tetracycline ointment) required further treatment with a therapeutic contact lens (non‐randomised). The use of the therapeutic contact lens cured one participant only. The other two participants stopped contact lens wear, one as they had a relapse and the other as they required frequent lens replacement. Anterior stromal puncture was not performed for these two participants as cure was achieved by a change in ointment. Therefore no participants were randomised into their treatment am. </p> <p>Epithelial debridement versus anterior stromal puncture (<a href="./references#CD001861-bbs2-0010" title="YamadaM , MashimaY . Three‐step treatment of recurrent corneal erosion. Folia Ophthalmologica Japonica1998;49(10):839‐43. ">Yamada 1998</a>). </p> <p>In the study conducted by <a href="./references#CD001861-bbs2-0010" title="YamadaM , MashimaY . Three‐step treatment of recurrent corneal erosion. Folia Ophthalmologica Japonica1998;49(10):839‐43. ">Yamada 1998</a>, if prophylactic therapy failed, participants were given a hydrogel (80% water content) therapeutic contact lens (not randomised) and if this was not successful they were then randomised to receive one of two treatments. </p> </section> <section id="CD001861-sec-0107"> <h5 class="title">7. Anterior stromal puncture versus therapeutic contact lens</h5> <p><a href="./references#CD001861-bbs2-0006" title="HykinPG , FossAE , PavesioC , DartJK . The natural history and management of recurrent corneal erosion: a prospective randomised trial. Eye1994;8(Pt 1):35‐40. ">Hykin 1994</a>, in the treatment arm of their trial, included participants presenting to Moorfields Eye Hospital, UK with an acute episode of recurrent corneal erosion where the erosion was off the visual axis and had not resolved in five days with topical chloramphenicol ointment, cycloplegia and patching. Only one participant met these criteria. </p> <p>The study compared therapeutic contact lens (hydrogel lens with 80% water content) versus anterior stromal puncture (<a href="./references#CD001861-bbs2-0006" title="HykinPG , FossAE , PavesioC , DartJK . The natural history and management of recurrent corneal erosion: a prospective randomised trial. Eye1994;8(Pt 1):35‐40. ">Hykin 1994</a>). </p> <section id="CD001861-sec-0108"> <h6 class="title">Recurrences requiring further treatment</h6> <p><a href="./references#CD001861-bbs2-0006" title="HykinPG , FossAE , PavesioC , DartJK . The natural history and management of recurrent corneal erosion: a prospective randomised trial. Eye1994;8(Pt 1):35‐40. ">Hykin 1994</a> had five participants requiring further treatment. Four were fitted with a contact lens and one person was excluded as they developed an anterior stromal infiltrate that was presumed to be infectious but was culture‐negative. Symptomatic control was achieved with a contact lens except for one participant who required a superficial keratectomy and then anterior stromal puncture resulting in almost complete abolition of their symptoms. </p> </section> <section id="CD001861-sec-0109"> <h6 class="title">Symptoms (pain score)</h6> <p><a href="./references#CD001861-bbs2-0006" title="HykinPG , FossAE , PavesioC , DartJK . The natural history and management of recurrent corneal erosion: a prospective randomised trial. Eye1994;8(Pt 1):35‐40. ">Hykin 1994</a> treated four of 82 participants (5%) with a contact lens (five instances, non‐randomised). In one participant (two eyes) the symptoms were not controlled and abrasion of the cornea with a Bard Parker blade was performed with symptom control. Anterior stromal puncture was performed in one participant and achieved symptom control. </p> </section> <section id="CD001861-sec-0110"> <h6 class="title">Adverse effects</h6> <p><a href="./references#CD001861-bbs2-0006" title="HykinPG , FossAE , PavesioC , DartJK . The natural history and management of recurrent corneal erosion: a prospective randomised trial. Eye1994;8(Pt 1):35‐40. ">Hykin 1994</a> reported no complications in the one participant who had anterior stromal puncture, and in the five eyes fitted with a contact lens. However, one participant with an acute episode of recurrent erosion developed an anterior stromal infiltrate that was presumed to be microbial keratitis (culture‐negative but resolution on topical antibiotic therapy); this is an uncommon complication of recurrent corneal erosion. </p> </section> <section id="CD001861-sec-0111"> <h6 class="title">Total number of erosions after treatment</h6> <p><a href="./references#CD001861-bbs2-0006" title="HykinPG , FossAE , PavesioC , DartJK . The natural history and management of recurrent corneal erosion: a prospective randomised trial. Eye1994;8(Pt 1):35‐40. ">Hykin 1994</a> did not report the total number of erosions after treatment. </p> </section> </section> <section id="CD001861-sec-0112"> <h5 class="title">8. Oral oxytetracycline and topical prednisolone (in addition to 'standard therapy') versus oral oxytetracycline (in addition to 'standard therapy') versus 'standard therapy' </h5> <p><a href="./references#CD001861-bbs2-0004" title="Hope‐RossMW , ChellPB , KervickGN , McDonnellPJ , JonesHS . Oral tetracycline in the treatment of recurrent corneal erosions. Eye1994;8(Pt 4):384‐8. ">Hope‐Ross 1994</a> included 30 participants with 'recalcitrant recurrent corneal erosion'; this was defined as participants with recurrent corneal erosion who had not responded to standard therapy. Over 80% of their participants had evidence of meibomian gland dysfunction. Participants were recruited from Birmingham and Midlands Eye Hospital, UK. </p> <p>The study compared standard therapy alone (preservative‐free cyclopentolate and chloramphenicol drops and paraffin (lubricating) ointment at night combined with manual debridement if the epithelium appeared wrinkled) versus oral tetracycline 250 mg twice daily for 12 weeks and lid hygiene plus standard therapy; and versus topical prednisolone 0.5% four times daily for one week, oral tetracycline 250 mg twice daily for 12 weeks and lid hygiene plus standard therapy (<a href="./references#CD001861-bbs2-0004" title="Hope‐RossMW , ChellPB , KervickGN , McDonnellPJ , JonesHS . Oral tetracycline in the treatment of recurrent corneal erosions. Eye1994;8(Pt 4):384‐8. ">Hope‐Ross 1994</a>). </p> <section id="CD001861-sec-0113"> <h6 class="title">Resolution of symptoms after treatment</h6> <p>This outcome was not reported.</p> </section> <section id="CD001861-sec-0114"> <h6 class="title">Total number of erosions after treatment</h6> <p><a href="./references#CD001861-bbs2-0004" title="Hope‐RossMW , ChellPB , KervickGN , McDonnellPJ , JonesHS . Oral tetracycline in the treatment of recurrent corneal erosions. Eye1994;8(Pt 4):384‐8. ">Hope‐Ross 1994</a> found a significant reduction in the total number of macroerosions with standard therapy plus oral tetracycline (two erosions for 10 participants, P = 0.04) and standard therapy, oral tetracycline and topical prednisolone (three erosions for 10 participants, P = 0.0003) but not for those on standard therapy alone (11 erosions for 10 participants, P = 0.66) using repeated measures analysis of variance over the 24‐week study period. </p> </section> <section id="CD001861-sec-0115"> <h6 class="title">Time to resolution of symptoms</h6> <p>This outcome was not reported.</p> </section> <section id="CD001861-sec-0116"> <h6 class="title">Recurrences after complete or partial resolution</h6> <p>This outcome was not reported.</p> </section> <section id="CD001861-sec-0117"> <h6 class="title">Time to recurrence</h6> <p>This outcome was not reported.</p> </section> <section id="CD001861-sec-0118"> <h6 class="title">Recurrences which required further treatment</h6> <p><a href="./references#CD001861-bbs2-0004" title="Hope‐RossMW , ChellPB , KervickGN , McDonnellPJ , JonesHS . Oral tetracycline in the treatment of recurrent corneal erosions. Eye1994;8(Pt 4):384‐8. ">Hope‐Ross 1994</a> reported an acceleration in healing rate from enrolment to study completion in participants on standard therapy plus oral tetracycline and those on standard therapy, oral tetracycline and topical prednisolone over the 24‐week study period. No acceleration in healing rate was found for those on standard therapy alone. The acceleration in healing rate was significantly different when participants receiving standard therapy plus oral tetracycline were compared to those on standard therapy alone (P = 0.001) and for those on standard therapy, oral tetracycline and topical prednisolone compared to standard treatment alone (P = 0.001). There was no difference in the accelerated healing rate when those on standard therapy plus oral tetracycline were compared to the group receiving standard therapy, oral tetracycline and topical prednisolone (P = 0.07). No participants required further treatment (epithelial debridement) during the study. </p> </section> <section id="CD001861-sec-0119"> <h6 class="title">Symptoms (pain score)</h6> <p><a href="./references#CD001861-bbs2-0004" title="Hope‐RossMW , ChellPB , KervickGN , McDonnellPJ , JonesHS . Oral tetracycline in the treatment of recurrent corneal erosions. Eye1994;8(Pt 4):384‐8. ">Hope‐Ross 1994</a> used a visual analogue scale to grade the severity of three symptoms (pain, light sensitivity and watering). They found a statistically significant decrease in symptom scores for participants receiving standard therapy plus oral tetracycline (P = 0.005) and standard therapy, oral tetracycline and topical prednisolone (P = 0.005) but not for those on standard therapy alone (P = 0.15) using repeated measures analysis of variance over the 24‐week study period. </p> </section> <section id="CD001861-sec-0120"> <h6 class="title">Adverse effects</h6> <p><a href="./references#CD001861-bbs2-0004" title="Hope‐RossMW , ChellPB , KervickGN , McDonnellPJ , JonesHS . Oral tetracycline in the treatment of recurrent corneal erosions. Eye1994;8(Pt 4):384‐8. ">Hope‐Ross 1994</a> reported two participants with altered bowel habit after starting oral tetracycline therapy. They did not specify ocular adverse effects. </p> </section> </section> </section> <section id="CD001861-sec-0121"> <h4 class="title">Prophylactic regimen to avert the development of recurrent corneal erosion</h4> <section id="CD001861-sec-0122"> <h5 class="title">Topical lubrication (combined with 'standard therapy') versus no topical lubrication ('standard therapy alone'). </h5> <p>One study examined a regimen to avert the development of recurrent corneal erosion following a traumatic corneal abrasion (<a href="./references#CD001861-bbs2-0003" title="EkeT , MorrisonDA , AustinDJ . Recurrent symptoms following traumatic corneal abrasion: prevalence, severity, and the effect of a simple regimen of prophylaxis. Eye1999;13(Pt 3a):345‐7. ">Eke 1999</a>). Participants with a traumatic corneal abrasion (following a fingernail injury) were recruited from the Eye Casualty Unit at the Royal Leicester Infirmary, UK. Topical lubrication nightly for two months combined with standard therapy (cyclopentolate drops and chloramphenicol ointment but no eye pad for five days) was compared with standard therapy alone. </p> <section id="CD001861-sec-0123"> <h6 class="title">Development of recurrent corneal erosions</h6> <p>At three months, on telephone interview, 28% of participants reported mostly mild ('non‐disabling') symptoms consistent with recurrent corneal erosion but only one person (in the control group) developed a confirmed macroform recurrent corneal erosion (RR 0.30, 95% CI 0.01 to 7.07; <a href="./references#CD001861-fig-0017" title="">Analysis 6.1</a>). There were more participants in the topical lubrication group who developed moderate (RR 3.64, 95% CI 0.44 to 29.87; <a href="./references#CD001861-fig-0017" title="">Analysis 6.1</a>) or mild and moderate symptoms (RR 3.33, 95% CI 1.08 to 10.26; <a href="./references#CD001861-fig-0017" title="">Analysis 6.1</a>) of recurrent corneal erosion at three months compared to the control group that received standard therapy alone. At two years, on review of the case notes, two of 42 participants had presented back to the study centre with recurrent corneal erosion, one in the treatment group and one in the control (RR 0.91, 95% CI 0.06 to 13.59; <a href="./references#CD001861-fig-0018" title="">Analysis 6.2</a>). </p> </section> <section id="CD001861-sec-0124"> <h6 class="title">Time to recurrence</h6> <p>This outcome was not reported.</p> </section> <section id="CD001861-sec-0125"> <h6 class="title">Recurrences which required further treatment</h6> <p>This outcome was not reported</p> </section> <section id="CD001861-sec-0126"> <h6 class="title">Symptoms (pain score)</h6> <p>This outcome was not reported.</p> </section> <section id="CD001861-sec-0127"> <h6 class="title">Adverse effects</h6> <p>No adverse effects were reported.</p> </section> </section> </section> <section id="CD001861-sec-0128"> <h4 class="title">Prophylactic regimens to prevent further episodes of recurrent corneal erosion</h4> <p>The studies conducted by <a href="./references#CD001861-bbs2-0006" title="HykinPG , FossAE , PavesioC , DartJK . The natural history and management of recurrent corneal erosion: a prospective randomised trial. Eye1994;8(Pt 1):35‐40. ">Hykin 1994</a> and <a href="./references#CD001861-bbs2-0010" title="YamadaM , MashimaY . Three‐step treatment of recurrent corneal erosion. Folia Ophthalmologica Japonica1998;49(10):839‐43. ">Yamada 1998</a> each had a 'prophylactic arm' that examined measures to prevent further episodes of recurrent corneal erosion once recurrent corneal erosion had been diagnosed. </p> <section id="CD001861-sec-0129"> <h5 class="title">Paraffin versus hypertonic saline</h5> <p><a href="./references#CD001861-bbs2-0006" title="HykinPG , FossAE , PavesioC , DartJK . The natural history and management of recurrent corneal erosion: a prospective randomised trial. Eye1994;8(Pt 1):35‐40. ">Hykin 1994</a> included in their prophylactic arm 98 participants with recurrent corneal erosion who had chronic symptoms (including those whose treatment had failed) and participants with an acute episode that resolved within five days after treatment with topical chloramphenicol ointment, cycloplegia and patching. <a href="./references#CD001861-bbs2-0006" title="HykinPG , FossAE , PavesioC , DartJK . The natural history and management of recurrent corneal erosion: a prospective randomised trial. Eye1994;8(Pt 1):35‐40. ">Hykin 1994</a> compared paraffin ointment to hypertonic saline ointment at night. </p> <section id="CD001861-sec-0130"> <h6 class="title">Total number of erosions after treatment</h6> <p>This outcome was not reported.</p> </section> <section id="CD001861-sec-0131"> <h6 class="title">Recurrences that a) improved and b) required further treatment</h6> <p><a href="./references#CD001861-bbs2-0006" title="HykinPG , FossAE , PavesioC , DartJK . The natural history and management of recurrent corneal erosion: a prospective randomised trial. Eye1994;8(Pt 1):35‐40. ">Hykin 1994</a> reported that 78 of 82 participants (95%) presenting with an acute episode of recurrent corneal erosion (prior to randomisation into the trial) were successfully treated with patching, cycloplegia and topical antibiotic ointment. Participants with resolved acute and chronic erosions were randomised into the prophylactic arm. In this arm, prophylactic treatment with paraffin or hypertonic saline ointment failed in five of 98 participants, as their symptoms were unacceptable or they had any acute erosion. The participants whose treatment of their acute episode was unsuccessful and those whose prophylactic measures had failed, entered the treatment arm of the trial. Four years after this study 94 of the 117 participants (80%) were surveyed; 55 participants (59%) were still symptomatic, with episodes of recurrent erosion occurring at least weekly in 24% and monthly in 51%. Participants with epithelial membrane dystrophy were more likely to be using topical lubricants than the trauma group (P = 0.02) (<a href="./references#CD001861-bbs2-0024" title="HeyworthP , MorletN , RaynerS , HykinP , DartJ . Natural history of recurrent erosion syndrome ‐ a 4 year review of 117 patients. British Journal of Ophthalmology1998;82(1):26‐8. ">Heyworth 1998</a>). </p> </section> <section id="CD001861-sec-0132"> <h6 class="title">Symptoms</h6> <p><a href="./references#CD001861-bbs2-0006" title="HykinPG , FossAE , PavesioC , DartJK . The natural history and management of recurrent corneal erosion: a prospective randomised trial. Eye1994;8(Pt 1):35‐40. ">Hykin 1994</a> reported that there was no difference in the effectiveness of the two ointments (paraffin and hypertonic saline) as prophylactic agents in their ability to control or abolish symptoms. Participants with epithelial basement membrane dystrophy had an increased risk of prophylactic failure in both groups (risk ratio 10.77) and required further treatment. </p> </section> <section id="CD001861-sec-0133"> <h6 class="title">Adverse effects</h6> <p>This outcome was not reported.</p> </section> </section> <section id="CD001861-sec-0134"> <h5 class="title">Tetracycline ointment versus hypertonic saline</h5> <p><a href="./references#CD001861-bbs2-0010" title="YamadaM , MashimaY . Three‐step treatment of recurrent corneal erosion. Folia Ophthalmologica Japonica1998;49(10):839‐43. ">Yamada 1998</a> included 23 participants with recurrent corneal erosion and compared tetracycline ointment to hypertonic saline at night. </p> <section id="CD001861-sec-0135"> <h6 class="title">Total number of erosions after treatment</h6> <p>This outcome was not reported.</p> </section> <section id="CD001861-sec-0136"> <h6 class="title">Recurrences that a) improved and b) required further treatment</h6> <p><a href="./references#CD001861-bbs2-0010" title="YamadaM , MashimaY . Three‐step treatment of recurrent corneal erosion. Folia Ophthalmologica Japonica1998;49(10):839‐43. ">Yamada 1998</a> reported that the objective signs of recurrent erosion disappeared for 6 of 10 participants given prophylaxis with hypertonic saline ointment and for 11 of 13 participants treated with tetracycline ointment (no statistical difference) (OR 3.67, 95% CI 0.51 to 26.22). </p> </section> <section id="CD001861-sec-0137"> <h6 class="title">Time to recurrence</h6> <p><a href="./references#CD001861-bbs2-0010" title="YamadaM , MashimaY . Three‐step treatment of recurrent corneal erosion. Folia Ophthalmologica Japonica1998;49(10):839‐43. ">Yamada 1998</a> found no difference between tetracycline ointment and hypertonic saline ointment (mean 5.6 versus 5.7 months; MD ‐0.10, 95% CI ‐2.82 to 2.62) in the time to resolution of the objective signs of recurrent corneal erosion. </p> </section> <section id="CD001861-sec-0138"> <h6 class="title">Symptoms</h6> <p><a href="./references#CD001861-bbs2-0010" title="YamadaM , MashimaY . Three‐step treatment of recurrent corneal erosion. Folia Ophthalmologica Japonica1998;49(10):839‐43. ">Yamada 1998</a> reported that 8 of 10 participants receiving hypertonic saline ointment and 12 of 13 receiving tetracycline ointment were "cured"; that is, they did not have symptoms and a relapse of corneal erosion for more than three months (OR 3.00, 95% 0.23 to 38.87). </p> </section> <section id="CD001861-sec-0139"> <h6 class="title">Adverse effects</h6> <p>This outcome was not reported.</p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD001861-sec-0140" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD001861-sec-0140"></div> <section id="CD001861-sec-0141"> <h3 class="title" id="CD001861-sec-0141">Summary of main results</h3> <p>The majority of acute episodes of recurrent corneal erosion can be treated with simple medical (standard) therapy (<a href="./references#CD001861-bbs2-0006" title="HykinPG , FossAE , PavesioC , DartJK . The natural history and management of recurrent corneal erosion: a prospective randomised trial. Eye1994;8(Pt 1):35‐40. ">Hykin 1994</a>). Following resolution of an episode of recurrent erosion there is no firm evidence from the studies to suggest the best prophylactic regimen in people with recurrent corneal erosion. There was no difference in the prophylactic effect of tetracycline ointment and hypertonic saline ointment (<a href="./references#CD001861-bbs2-0010" title="YamadaM , MashimaY . Three‐step treatment of recurrent corneal erosion. Folia Ophthalmologica Japonica1998;49(10):839‐43. ">Yamada 1998</a>) or between paraffin (lubricating) ointment and hypertonic saline ointment (<a href="./references#CD001861-bbs2-0006" title="HykinPG , FossAE , PavesioC , DartJK . The natural history and management of recurrent corneal erosion: a prospective randomised trial. Eye1994;8(Pt 1):35‐40. ">Hykin 1994</a>). Indeed, despite prophylaxis with ointment many participants may continue to suffer with symptoms of recurrent erosion and require ongoing therapy (<a href="./references#CD001861-bbs2-0003" title="EkeT , MorrisonDA , AustinDJ . Recurrent symptoms following traumatic corneal abrasion: prevalence, severity, and the effect of a simple regimen of prophylaxis. Eye1999;13(Pt 3a):345‐7. ">Eke 1999</a>). Current clinical practice is to treat an episode of recurrent corneal erosion with antibiotic or lubricating ointment or drops, or a combination of some or all of these, which may be continued once the episode has resolved to prevent further episodes of recurrent corneal erosion. Diamond burr polishing has been shown to reduce episodes of recurrent corneal erosions compared to epithelial debridement (<a href="./references#CD001861-bbs2-0009" title="WongVW , ChiSC , LamDS . Diamond burr polishing for recurrent corneal erosions:results from a prospective randomized controlled trial. Cornea2009;28(2):152‐6. ">Wong 2009</a>). Comparison between alcohol delamination and phototherapeutic keratectomy showed no difference in resolution or recurrence rates (<a href="./references#CD001861-bbs2-0002" title="ChanE , JhanjiV , ConstantinouM , AmielH , SnibsonGR , VajpayeeRB . A randomised controlled trial of alcohol delamination and phototherapeutic keratectomy for the treatment of recurrent corneal erosion syndrome. British Journal of Ophthalmology2014;98(2):166‐71. ">Chan 2014</a>). </p> <p>For averting the development of recurrent corneal erosion following a traumatic corneal abrasion due to a fingernail injury, lubricating ointment at night for two months in addition to standard treatment (cyclopentolate drops, then chloramphenicol ointment for five days) led to increased development of the symptoms of recurrent corneal erosion at three months compared to standard therapy alone (<a href="./references#CD001861-bbs2-0003" title="EkeT , MorrisonDA , AustinDJ . Recurrent symptoms following traumatic corneal abrasion: prevalence, severity, and the effect of a simple regimen of prophylaxis. Eye1999;13(Pt 3a):345‐7. ">Eke 1999</a>). This was the only included study to examine measures to avert the development of recurrent corneal erosion following traumatic corneal abrasion; clearly more studies are needed. It is common practice to treat a traumatic corneal abrasion with antibiotic and/or lubricating ointment, however, such therapy is not always continued for months. </p> <p>Adverse effects for these treatments were limited. An early study reported that excimer laser did not change the vision, intraocular pressure or refraction (<a href="./references#CD001861-bbs2-0007" title="OhmanL , FagerholmP . The influence of excimer laser ablation on recurrent corneal erosions: a prospective randomized study. Cornea1998;17(4):349‐52. ">Ohman 1998</a>). However, hyperopic shift (<a href="./references#CD001861-bbs2-0005" title="HützWW ,  StachsO ,  HengererF ,  EckhardtB . Efficacy of different excimer laser techniques in the management of recurrent corneal erosions. Ophthalmic Surgery, Lasers and Imaging2010;41(6):635‐41. ">Hutz 2010</a>) and self‐resolving subepithelial haze (<a href="./references#CD001861-bbs2-0002" title="ChanE , JhanjiV , ConstantinouM , AmielH , SnibsonGR , VajpayeeRB . A randomised controlled trial of alcohol delamination and phototherapeutic keratectomy for the treatment of recurrent corneal erosion syndrome. British Journal of Ophthalmology2014;98(2):166‐71. ">Chan 2014</a>) have been reported with a subepithelial excimer laser ablation technique for recurrent erosion. Diamond burr polishing can cause astigmatism, although the rate of this complication was less than for epithelial debridement (<a href="./references#CD001861-bbs2-0009" title="WongVW , ChiSC , LamDS . Diamond burr polishing for recurrent corneal erosions:results from a prospective randomized controlled trial. Cornea2009;28(2):152‐6. ">Wong 2009</a>). Oral tetracyclines disturbed the gastrointestinal system in two participants (<a href="./references#CD001861-bbs2-0004" title="Hope‐RossMW , ChellPB , KervickGN , McDonnellPJ , JonesHS . Oral tetracycline in the treatment of recurrent corneal erosions. Eye1994;8(Pt 4):384‐8. ">Hope‐Ross 1994</a>) and therapeutic contact lens wear was complicated by loss of the epithelium or contact lens, or both (<a href="./references#CD001861-bbs2-0008" title="WilliamsR , BuckleyRJ . Pathogenesis and treatment of recurrent erosion. British Journal of Ophthalmology1985;69(6):435‐7. ">Williams 1985</a>). Newer lens styles may avoid such complications (<a href="./references#CD001861-bbs2-0001" title="AhadMA , AnadanM , TahV , DhingraS , LeylandM . Randomized controlled study of ocular lubrication versus bandage contact lens in the primary treatment of recurrent corneal erosion syndrome. Cornea2013;32(10):1311‐4. ">Ahad 2013</a>). The number of participants treated in the studies by anterior stromal puncture or superficial keratectomy was too small for conclusions to be reached on the effectiveness and adverse effects of these treatments (<a href="./references#CD001861-bbs2-0002" title="ChanE , JhanjiV , ConstantinouM , AmielH , SnibsonGR , VajpayeeRB . A randomised controlled trial of alcohol delamination and phototherapeutic keratectomy for the treatment of recurrent corneal erosion syndrome. British Journal of Ophthalmology2014;98(2):166‐71. ">Chan 2014</a>; <a href="./references#CD001861-bbs2-0006" title="HykinPG , FossAE , PavesioC , DartJK . The natural history and management of recurrent corneal erosion: a prospective randomised trial. Eye1994;8(Pt 1):35‐40. ">Hykin 1994</a>; <a href="./references#CD001861-bbs2-0010" title="YamadaM , MashimaY . Three‐step treatment of recurrent corneal erosion. Folia Ophthalmologica Japonica1998;49(10):839‐43. ">Yamada 1998</a>). </p> </section> <section id="CD001861-sec-0142"> <h3 class="title" id="CD001861-sec-0142">Overall completeness and applicability of evidence</h3> <p>The limited evidence from the studies suggests that the symptoms and signs of recurrent corneal erosion may be reduced or controlled by one of the following treatments: the addition of oral tetracycline 250 mg twice daily for 12 weeks or topical prednisolone 0.5% four times daily for one week, or both, to standard treatment (preservative‐free cyclopentolate and chloramphenicol drops, and paraffin (lubricating) ointment at night combined with manual debridement of loose epithelium) (<a href="./references#CD001861-bbs2-0004" title="Hope‐RossMW , ChellPB , KervickGN , McDonnellPJ , JonesHS . Oral tetracycline in the treatment of recurrent corneal erosions. Eye1994;8(Pt 4):384‐8. ">Hope‐Ross 1994</a>); or excimer laser ablation alone (<a href="./references#CD001861-bbs2-0002" title="ChanE , JhanjiV , ConstantinouM , AmielH , SnibsonGR , VajpayeeRB . A randomised controlled trial of alcohol delamination and phototherapeutic keratectomy for the treatment of recurrent corneal erosion syndrome. British Journal of Ophthalmology2014;98(2):166‐71. ">Chan 2014</a>; <a href="./references#CD001861-bbs2-0005" title="HützWW ,  StachsO ,  HengererF ,  EckhardtB . Efficacy of different excimer laser techniques in the management of recurrent corneal erosions. Ophthalmic Surgery, Lasers and Imaging2010;41(6):635‐41. ">Hutz 2010</a>) or in addition to mechanical debridement (<a href="./references#CD001861-bbs2-0007" title="OhmanL , FagerholmP . The influence of excimer laser ablation on recurrent corneal erosions: a prospective randomized study. Cornea1998;17(4):349‐52. ">Ohman 1998</a>). However, participants in <a href="./references#CD001861-bbs2-0004" title="Hope‐RossMW , ChellPB , KervickGN , McDonnellPJ , JonesHS . Oral tetracycline in the treatment of recurrent corneal erosions. Eye1994;8(Pt 4):384‐8. ">Hope‐Ross 1994</a> had a high rate of meibomian gland dysfunction (<a href="./references#CD001861-bbs2-0027" title="Hope‐RossMW , ChellPB , KervickGN , McDonnellPJ . Recurrent corneal erosion: clinical features. Eye1994;8(Pt 4):373‐7. ">Hope‐Ross 1994a</a>); oral tetracyclines and topical prednisolone may have improved this condition rather than recurrent corneal erosion. Although a previous study found that therapeutic contact lenses were inferior to lubricants and had a high complication rate (<a href="./references#CD001861-bbs2-0008" title="WilliamsR , BuckleyRJ . Pathogenesis and treatment of recurrent erosion. British Journal of Ophthalmology1985;69(6):435‐7. ">Williams 1985</a>), newer lenses with higher oxygen transmission are now available. Indeed newer generation contact lenses are currently used to treat some episodes of recurrent corneal erosion that do not respond to medical therapy and to prevent further episodes and this is supported by new data that suggest non‐inferiority and reduced complications (<a href="./references#CD001861-bbs2-0001" title="AhadMA , AnadanM , TahV , DhingraS , LeylandM . Randomized controlled study of ocular lubrication versus bandage contact lens in the primary treatment of recurrent corneal erosion syndrome. Cornea2013;32(10):1311‐4. ">Ahad 2013</a>). </p> <p>For recurrent erosion it is difficult to assess accurately on examination the number of erosions a person may have had after treatment, as erosions typically resolve quickly and therefore may be missed if the person is examined only at fixed intervals. Patient history (symptoms) may provide a more accurate measure of the number of erosions experienced by a patient. However, the studies we examined measured a variety of symptoms in different ways, and no study used a validated instrument for their measurement. Non‐validated assessments are open to bias and ambiguity. Future studies should use standardised and validated measures to assess participants' symptoms in order to provide an appropriate outcome measure for studies of recurrent corneal erosion. The examiner and participants should be masked, though for studies of therapeutic contact lens wear, patching and ointment use this may not be possible for participants. Appropriate safety information is also essential when selecting treatments. Standardised ocular and, if appropriate, systemic adverse effects should be explicitly collected and stated by all studies to allow treatment success to be weighed against the risks. The studies assessed in this review do, however, highlight regimens that are in use for recurrent erosion or its prevention and may provide the direction for future studies. Future studies of recurrent corneal erosion should standardise inclusion and exclusion criteria, improve the allocation process, ensure masking of participants and examiners where possible, use validated outcome measures, define standard therapy and, like the current studies, ensure there are no significant losses to follow‐up. </p> </section> <section id="CD001861-sec-0143"> <h3 class="title" id="CD001861-sec-0143">Quality of the evidence</h3> <p>The included studies were heterogeneous and possibly of poor quality. In particular, inclusion criteria were variable, allocation concealment was inadequate and therefore a source of potential bias, masking was unclear and outcome measures were not validated. We made attempts to contact the study authors to clarify issues regarding the possibility of allocation, performance, detection and attrition bias in these studies. However, we received no response from them. Three of the seven studies were published prior to publication of the CONSORT statement in 1996 and this may account for their variable quality. The variability and inadequacies of these studies meant that it was not appropriate to directly compare the studies; thus, it could not be determined if one prophylaxis or treatment regimen was superior to another or to no treatment. Indeed, the treatment regimens examined in the studies are all utilised in current clinical practice, reflecting the lack of firm evidence for the efficacy or adverse effects of any treatment. The one study that examined a regimen to avert the development of recurrent corneal erosion following traumatic corneal abrasion was of poor quality and did not provide firm evidence for the development of clinical guidelines. </p> <p>Two additional studies included in this update, <a href="./references#CD001861-bbs2-0001" title="AhadMA , AnadanM , TahV , DhingraS , LeylandM . Randomized controlled study of ocular lubrication versus bandage contact lens in the primary treatment of recurrent corneal erosion syndrome. Cornea2013;32(10):1311‐4. ">Ahad 2013</a> and <a href="./references#CD001861-bbs2-0002" title="ChanE , JhanjiV , ConstantinouM , AmielH , SnibsonGR , VajpayeeRB . A randomised controlled trial of alcohol delamination and phototherapeutic keratectomy for the treatment of recurrent corneal erosion syndrome. British Journal of Ophthalmology2014;98(2):166‐71. ">Chan 2014</a>, showed substantially superior quality in their assessment of bias when judged using current standards. However, the fact that we have included only two additional studies since the last update highlights the difficulty in performing randomised controlled studies for recurrent corneal erosion. Improved collaboration, such as the establishment of an international working group, may be needed to improve the quality of evidence to guide the management of recurrent corneal erosion. </p> </section> <section id="CD001861-sec-0144"> <h3 class="title" id="CD001861-sec-0144">Potential biases in the review process</h3> <p>We carefully adhered to the study protocol according to the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD001861-bbs2-0026" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011b</a>), thus minimising any potential bias that may arise in the review process. </p> </section> <section id="CD001861-sec-0145"> <h3 class="title" id="CD001861-sec-0145">Agreements and disagreements with other studies or reviews</h3> <p>Other reviews have often included non‐randomised trials and focused on different treatment modalities without substantial evidence on the balance of efficacy and adverse effects data. It is difficult to compare opinions with different reviews as the scopes of the reviews are often different. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD001861-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/urn:x-wiley:14651858:media:CD001861:CD001861-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_t/tCD001861-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram" data-id="CD001861-fig-0001" src="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_n/nCD001861-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/full#CD001861-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_n/nCD001861-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001861-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/urn:x-wiley:14651858:media:CD001861:CD001861-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_t/tCD001861-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD001861-fig-0002" src="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_n/nCD001861-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/full#CD001861-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_n/nCD001861-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001861-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/urn:x-wiley:14651858:media:CD001861:CD001861-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_t/tCD001861-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD001861-fig-0003" src="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_n/nCD001861-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/full#CD001861-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_n/nCD001861-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001861-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/urn:x-wiley:14651858:media:CD001861:CD001861-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_t/tCD001861-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Therapeutic contact lens versus topical lubrication, Outcome 1 Resolution of symptoms after treatment." data-id="CD001861-fig-0004" src="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_n/nCD001861-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Therapeutic contact lens versus topical lubrication, Outcome 1 Resolution of symptoms after treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/references#CD001861-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_n/nCD001861-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001861-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/urn:x-wiley:14651858:media:CD001861:CD001861-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_t/tCD001861-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Therapeutic contact lens versus topical lubrication, Outcome 2 Recurrence after partial or complete resolution." data-id="CD001861-fig-0005" src="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_n/nCD001861-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Therapeutic contact lens versus topical lubrication, Outcome 2 Recurrence after partial or complete resolution. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/references#CD001861-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_n/nCD001861-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001861-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/urn:x-wiley:14651858:media:CD001861:CD001861-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_t/tCD001861-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Therapeutic contact lens versus topical lubrication, Outcome 3 Pain." data-id="CD001861-fig-0006" src="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_n/nCD001861-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Therapeutic contact lens versus topical lubrication, Outcome 3 Pain.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/references#CD001861-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_n/nCD001861-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001861-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/urn:x-wiley:14651858:media:CD001861:CD001861-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_t/tCD001861-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Phototherapeutic keratectomy (PTK) versus alcohol delamination (ALD), Outcome 1 Resolution of symptoms after treatment." data-id="CD001861-fig-0007" src="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_n/nCD001861-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Phototherapeutic keratectomy (PTK) versus alcohol delamination (ALD), Outcome 1 Resolution of symptoms after treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/references#CD001861-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_n/nCD001861-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001861-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/urn:x-wiley:14651858:media:CD001861:CD001861-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_t/tCD001861-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Phototherapeutic keratectomy (PTK) versus alcohol delamination (ALD), Outcome 2 Recurrence after partial or complete resolution." data-id="CD001861-fig-0008" src="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_n/nCD001861-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Phototherapeutic keratectomy (PTK) versus alcohol delamination (ALD), Outcome 2 Recurrence after partial or complete resolution. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/references#CD001861-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_n/nCD001861-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001861-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/urn:x-wiley:14651858:media:CD001861:CD001861-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_t/tCD001861-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Phototherapeutic keratectomy (PTK) versus alcohol delamination (ALD), Outcome 3 Pain score." data-id="CD001861-fig-0009" src="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_n/nCD001861-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Phototherapeutic keratectomy (PTK) versus alcohol delamination (ALD), Outcome 3 Pain score. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/references#CD001861-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_n/nCD001861-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001861-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/urn:x-wiley:14651858:media:CD001861:CD001861-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_t/tCD001861-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Phototherapeutic keratectomy (PTK) versus alcohol delamination (ALD), Outcome 4 Recurrence requiring further treatment." data-id="CD001861-fig-0010" src="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_n/nCD001861-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Phototherapeutic keratectomy (PTK) versus alcohol delamination (ALD), Outcome 4 Recurrence requiring further treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/references#CD001861-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_n/nCD001861-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001861-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/urn:x-wiley:14651858:media:CD001861:CD001861-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_t/tCD001861-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Diamond burr superficial keratectomy versus epithelial debridement, Outcome 1 Recurrence after partial or complete resolution." data-id="CD001861-fig-0011" src="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_n/nCD001861-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Diamond burr superficial keratectomy versus epithelial debridement, Outcome 1 Recurrence after partial or complete resolution. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/references#CD001861-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_n/nCD001861-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001861-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/urn:x-wiley:14651858:media:CD001861:CD001861-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_t/tCD001861-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Diamond burr superficial keratectomy versus epithelial debridement, Outcome 2 Corneal haze." data-id="CD001861-fig-0012" src="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_n/nCD001861-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Diamond burr superficial keratectomy versus epithelial debridement, Outcome 2 Corneal haze. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/references#CD001861-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_n/nCD001861-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001861-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/urn:x-wiley:14651858:media:CD001861:CD001861-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_t/tCD001861-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Transepithelial verus subepithelial excimer laser ablation, Outcome 1 Recurrence of complete or partial resolution." data-id="CD001861-fig-0013" src="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_n/nCD001861-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Transepithelial verus subepithelial excimer laser ablation, Outcome 1 Recurrence of complete or partial resolution. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/references#CD001861-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_n/nCD001861-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001861-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/urn:x-wiley:14651858:media:CD001861:CD001861-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_t/tCD001861-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Excimer laser (after epithelial debridement) versus no excimer laser (after epithelial debridement), Outcome 1 Recurrence after partial or complete resolution." data-id="CD001861-fig-0014" src="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_n/nCD001861-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Excimer laser (after epithelial debridement) versus no excimer laser (after epithelial debridement), Outcome 1 Recurrence after partial or complete resolution. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/references#CD001861-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_n/nCD001861-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001861-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/urn:x-wiley:14651858:media:CD001861:CD001861-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_t/tCD001861-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Excimer laser (after epithelial debridement) versus no excimer laser (after epithelial debridement), Outcome 2 Symptoms (pain score)." data-id="CD001861-fig-0015" src="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_n/nCD001861-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Excimer laser (after epithelial debridement) versus no excimer laser (after epithelial debridement), Outcome 2 Symptoms (pain score). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/references#CD001861-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_n/nCD001861-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001861-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/urn:x-wiley:14651858:media:CD001861:CD001861-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_t/tCD001861-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Excimer laser (after epithelial debridement) versus no excimer laser (after epithelial debridement), Outcome 3 Recurrences requiring further treatment." data-id="CD001861-fig-0016" src="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_n/nCD001861-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Excimer laser (after epithelial debridement) versus no excimer laser (after epithelial debridement), Outcome 3 Recurrences requiring further treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/references#CD001861-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_n/nCD001861-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001861-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/urn:x-wiley:14651858:media:CD001861:CD001861-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_t/tCD001861-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Topical lubrication versus no topical lubrication (prophylaxis), Outcome 1 Development of recurrent corneal erosions at 3 months." data-id="CD001861-fig-0017" src="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_n/nCD001861-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Topical lubrication versus no topical lubrication (prophylaxis), Outcome 1 Development of recurrent corneal erosions at 3 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/references#CD001861-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_n/nCD001861-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001861-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/urn:x-wiley:14651858:media:CD001861:CD001861-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_t/tCD001861-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Topical lubrication versus no topical lubrication (prophylaxis), Outcome 2 Development of recurrent corneal erosions at 3 months." data-id="CD001861-fig-0018" src="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_n/nCD001861-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 Topical lubrication versus no topical lubrication (prophylaxis), Outcome 2 Development of recurrent corneal erosions at 3 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/references#CD001861-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/media/CDSR/CD001861/image_n/nCD001861-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD001861-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Therapeutic contact lens versus topical lubrication for the treatment of recurrent corneal erosion syndrome</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Therapeutic contact lens versus topical lubrication</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population</b>: people with recurrent corneal erosion syndrome without previous surgical intervention </p> <p><b>Settings</b>: outpatient </p> <p><b>Intervention</b>: therapeutic contact lens </p> <p><b>Comparison</b>: topical lubrication </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Topical lubrication</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Therapeutic contact lens</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Resolution of symptoms after treatment</b> </p> <p>Follow‐up: 4 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>730 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>708 per 1000</p> <p>(453 to 1000)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.97 (0.62 to 1.53)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29 participants</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Recurrence after complete or partial resolution</b> </p> <p>Follow‐up: 7 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>67 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>72 per 1000</p> <p>(0 to 1000)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.07</p> <p>(0.07 to 15.54)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29 participants</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single study only followed up participants with complete resolution to screen for recurrence </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Time to recurrence</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Outcome not reported for this comparison</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Recurrences requiring further treatment</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Neither study reported this outcome but one study stated that the two recurrences were minor symptoms with no obvious macroerosions. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptoms (pain score)</b> </p> <p>Follow‐up: 3 months</p> <p>(higher score indicates more pain, unclear range of scale but probably 0 to 10)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean pain score with topical lubrication was <b>2</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean pain score with therapeutic contact lens was <b>1</b> higher (worse) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29 participants</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Visual analogue scale range not specified, standard deviations not reported</p> <p>One other study of 24 participants reported more pain in contact lens group (RR 3.15, 95% CI 1.10, 9.06) but contact lens used is no longer in common use </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse effects: corneal haze</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The more recent study did not report this outcome. The older study using a lens no longer in common use reported more complications with the contact lens. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse effects: astigmatism</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Outcome not reported for this comparison</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence</p> <p><b>High‐certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect. </p> <p><b>Moderate‐certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. </p> <p><b>Low‐certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect. </p> <p><b>Very low‐certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded one level for risk of bias due to serious limitation in study design and execution (the single study has a high risk of bias due to lack of blinding of study personnel).<br/> <sup>2</sup>Downgraded one level for imprecision.<br/> 3Downgraded two levels for imprecision (very few events).<br/> <sup>4</sup>Downgraded one level for indirectness as contact lens no longer in use. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Therapeutic contact lens versus topical lubrication for the treatment of recurrent corneal erosion syndrome</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/full#CD001861-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD001861-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Phototherapeutic keratectomy versus alcohol delamination for the treatment of recurrent corneal erosion syndrome</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Phototherapeutic keratectomy versus alcohol delamination</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population</b>: people with recurrent corneal erosion syndrome without previous surgical intervention </p> <p><b>Settings</b>: outpatient </p> <p><b>Intervention</b>: phototherapeutic keratectomy (after epithelial debridement) </p> <p><b>Comparison</b>: alcohol delamination and sham excimer laser (after epithelial debridement) </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Alcohol delamination</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Phototherapeutic keratectomy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Resolution of symptoms after treatment</b> </p> <p>Follow‐up: 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>590 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>378 per 1000 (177 to 797)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.64 (0.30 to 1.35)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33 participants</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Recurrence after complete or partial resolution</b> </p> <p>Follow‐up: 24 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>294 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>373 per 1000</p> <p>(141 to 991)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 1.27</p> <p>(0.48 to 3.37)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33 participants</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>All participants were followed for recurrence up to 24 months</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time to recurrence</b> </p> <p>Follow‐up: 24 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean time to recurrence in the control group was</p> <p><b>6 months</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean time to recurrence in the intervention group was <b>0.5 months longer</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33 participants</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard deviations not reported but difference between groups was reported to be not statistically significant </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Recurrences requiring further treatment</b> </p> <p>Follow‐up: 24 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>176 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>125 per 1000</p> <p>(25 to 651)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.71</p> <p>(0.14 to 3.70)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33 participants</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>2,3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Further treatment of choice not indicated</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Symptoms (pain score)</b> </p> <p>(scale 0‐10)</p> <p>(lower scores indicate less pain)</p> <p>Follow‐up: 24 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean pain score in the control group was<b>1.7</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean pain score in the intervention group was <b>0.7 lower</b> (2.23 lower to 0.83 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33 participants</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse effects: corneal haze</b> </p> <p>Follow‐up: 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign=""> <p>There were no events in either group.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33 participants</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>2,3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse effects: astigmatism</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>Outcome not reported for this comparison</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence</p> <p><b>High‐certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect. </p> <p><b>Moderate‐certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. </p> <p><b>Low‐certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect. </p> <p><b>Very low‐certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded one level for imprecision: small sample size<br/> <sup>2</sup>Downgraded one level for limitation in design and execution: the single study has a high risk of bias due to lack of blinding of study personnel<br/> <sup>3</sup>Downgraded two levels for imprecision: small sample size, very few or no events </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Phototherapeutic keratectomy versus alcohol delamination for the treatment of recurrent corneal erosion syndrome</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/full#CD001861-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD001861-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Diamond burr superficial keratectomy (after epithelial debridement) versus sham diamond burr (after epithelial debridement) for the treatment of recurrent corneal erosion syndrome</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Diamond burr superficial keratectomy (after epithelial debridement) versus sham diamond burr (after epithelial debridement)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population</b>: people with recurrent corneal erosion syndrome without other corneal basement membrane dystrophy </p> <p><b>Settings</b>: outpatient </p> <p><b>Intervention</b>: diamond burr superficial keratectomy after epithelial debridement </p> <p><b>Comparison</b>: sham diamond burr superficial keratectomy after epithelial debridement </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Sham diamond burr superficial keratectomy after epithelial debridement</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Diamond burr superficial keratectomy after epithelial debridement</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Resolution of symptoms after treatment</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>Outcome not reported for this comparison</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Recurrence after complete or partial resolution</b> </p> <p>Follow‐up: 6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>565 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>40 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.07 (0.01 to 0.50)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48 participants</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single study reported major recurrence defined as those requiring ophthalmologist assessment </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time to recurrence</b> </p> <p>Follow‐up: 6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean time to recurrence with sham diamond burr was <b>2.4 months</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean time to recurrence in the intervention group was <b>3.6 months longer</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48 participants</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Only one event in diamond burr group</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Recurrences requiring further treatment</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>Outcome not reported for this comparison</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Symptoms (pain score)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>Outcome not reported for this comparison</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse effects: corneal haze</b> </p> <p>Follow‐up: 6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>43 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>40 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.92 (0.06‐13.87)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48 participants</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Four point scale was used to grade degree of haze (absent, mild, moderate, severe). Single study reported 1 mild haze and 1 moderate in the control and intervention groups respectively. Haze was analysed as dichotomous variable. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse effects: astigmatism</b> (mean magnitude) measured in dioptres. Higher value is worse astigmatism. </p> <p>Follow‐up: 3 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean astigmatism in the sham diamond burr group was <b>0.88 dioptres</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean astigmatism in the diamond burr group was <b>0.44 dioptres less (better)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48 participants</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No standard deviations available</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence</p> <p><b>High‐certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect. </p> <p><b>Moderate‐certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. </p> <p><b>Low‐certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect. </p> <p><b>Very low‐certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded one level for imprecision: small sample size ‐ did not reach target sample size per included power calculations.<br/> <sup>2</sup> Downgraded two levels for imprecision: small sample size ‐ did not reach target sample size per included power calculations, unable to estimate event rate.<br/> <sup>3</sup> Downgraded two levels for imprecision: small sample size ‐ did not reach target sample size per included power calculations, wide confidence interval. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Diamond burr superficial keratectomy (after epithelial debridement) versus sham diamond burr (after epithelial debridement) for the treatment of recurrent corneal erosion syndrome</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/full#CD001861-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD001861-tbl-0004"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Included studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Treatment/ prophylaxis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Country</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>No. of participants*</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Average age</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Age range</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Percentage women</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention 1</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention 2</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Comparator</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Co‐intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Duration of treatment</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001861-bbs2-0001" title="AhadMA , AnadanM , TahV , DhingraS , LeylandM . Randomized controlled study of ocular lubrication versus bandage contact lens in the primary treatment of recurrent corneal erosion syndrome. Cornea2013;32(10):1311‐4. ">Ahad 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UK</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21‐73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Therapeutic contact lens</b> </p> <p>Air Optix Night and Day lenses (silicon hydrogel with 24% water, CIBA vision), replaced every 30 days </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Topical lubricant</b> carbomer (celluvisc) 0.5% 4 times daily and lacrilube at night </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001861-bbs2-0002" title="ChanE , JhanjiV , ConstantinouM , AmielH , SnibsonGR , VajpayeeRB . A randomised controlled trial of alcohol delamination and phototherapeutic keratectomy for the treatment of recurrent corneal erosion syndrome. British Journal of Ophthalmology2014;98(2):166‐71. ">Chan 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Australia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Phototherapeutic keratectomy</b> epithelium removed with blade, excimer laser treatment (Zyoptix, Bausch and Lomb) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Alcohol delamination</b> epithelium removed with blade, simulated excimer laser </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Stat diclofenac (Voltaren Ophthal Eye Drops), chloramphenicol 0.5% (Chlorsig, Sigma Pharmaceuticals), prednisolone phosphate 0.5% (Minims, Bausch and Lomb), postoperative chloramphenicol and fluorometholone and therapeutic contact lens paraffin based lubricating ointment at night for 3 months following treatment participants with persistent or recurring symptoms causing discomfort were offered repeat phototherapeutic keratectomy </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001861-bbs2-0003" title="EkeT , MorrisonDA , AustinDJ . Recurrent symptoms following traumatic corneal abrasion: prevalence, severity, and the effect of a simple regimen of prophylaxis. Eye1999;13(Pt 3a):345‐7. ">Eke 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prophylaxis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UK</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Topical lubrication</b> Lacrilube, Allergan at night </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>No topical lubrication</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cyclopentolate 1% drops and chloramphenicol ointment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001861-bbs2-0004" title="Hope‐RossMW , ChellPB , KervickGN , McDonnellPJ , JonesHS . Oral tetracycline in the treatment of recurrent corneal erosions. Eye1994;8(Pt 4):384‐8. ">Hope‐Ross 1994</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UK</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27‐77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>57%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral <b>oxytetracycline</b> 250 mg twice a day and topical <b>prednisolone 0.5%</b> four times a day and daily lid hygiene </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral <b>oxytetracycline</b> 250 mg twice a day and daily lid hygiene </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>No oxytetracycline or prednisolone</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Simple eye ointment. Macroerosions were treated with a single dose of cyclopentolate 1% and chloramphenicol followed by patching for 24 h and analgesia as required and paraffin (lubricating) ointment at night combined with manual debridement if the epithelium appeared wrinkled </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24 weeks for standard therapy, 12 weeks for tetracycline and 7 days for prednisolone</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001861-bbs2-0005" title="HützWW ,  StachsO ,  HengererF ,  EckhardtB . Efficacy of different excimer laser techniques in the management of recurrent corneal erosions. Ophthalmic Surgery, Lasers and Imaging2010;41(6):635‐41. ">Hutz 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Germany</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR but inclusion criteria specified &gt; 20 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR but inclusion criteria specified &gt; 20 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Transepithelial excimer laser ablation</b> </p> <p>(20 pulses of 193 nm)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Subepithelial excimer laser ablation</b> </p> <p>(20 pulses of 193 nm). Subepithelial group also received additional contact bandages postoperatively until re‐epithelialisation </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>One‐off procedure</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001861-bbs2-0006" title="HykinPG , FossAE , PavesioC , DartJK . The natural history and management of recurrent corneal erosion: a prospective randomised trial. Eye1994;8(Pt 1):35‐40. ">Hykin 1994</a> </p> <p>Prophylaxis study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prophylaxis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>UK</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>14‐80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>53%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Topical lubrication</b> paraffin ointment nightly </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> <p>hypertonic saline nightly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3‐6 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001861-bbs2-0006" title="HykinPG , FossAE , PavesioC , DartJK . The natural history and management of recurrent corneal erosion: a prospective randomised trial. Eye1994;8(Pt 1):35‐40. ">Hykin 1994</a> </p> <p>Treatment study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Anterior stromal puncture</b> </p> <p>purpose‐<br/> designed needle (Look Inc.) with a 0.1‐0.3 mm<br/> turned end. Puncture marks were made 1 mm apart to the level of Bowman's membrane over the area of affected corneal epithelium and extending for 1 mm onto normal surrounding cornea. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Therapeutic contact lens</b> </p> <p>hydrogel (80% water content) soft contact lenses, left in situ for 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If symptoms not controlled, a partial superficial keratectomy (anterior to Bowman's membrane) was performed. If this failed then the participant was withdrawn from study and total superficial keratectomy considered </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 weeks</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001861-bbs2-0007" title="OhmanL , FagerholmP . The influence of excimer laser ablation on recurrent corneal erosions: a prospective randomized study. Cornea1998;17(4):349‐52. ">Ohman 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sweden</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21‐75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Excimer laser ablation</b> (after epithelial debridement) </p> <p>Summit ExciMed 200 central ablation of 5 microns with diameter of 6.5 mm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>No excimer laser ablation</b> (epithelial debridement alone) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Epithelial debridement using a Beaver blade or a sponge. Patch overnight. Antibiotic ointment, chloramphenicol </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>One‐off procedure followed by topical treatment 3 times per day for 3‐4 days</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001861-bbs2-0008" title="WilliamsR , BuckleyRJ . Pathogenesis and treatment of recurrent erosion. British Journal of Ophthalmology1985;69(6):435‐7. ">Williams 1985</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UK</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22‐60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Therapeutic contact lens</b> hydrogel high water content lens (Duragel 75 plano) with chloramphenicol 2 times a day. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Topical lubrication</b> hypromellose drops 4 times a day and paraffin ointment (oculentum simplex) nightly </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 weeks</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001861-bbs2-0009" title="WongVW , ChiSC , LamDS . Diamond burr polishing for recurrent corneal erosions:results from a prospective randomized controlled trial. Cornea2009;28(2):152‐6. ">Wong 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20‐70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>56%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Diamond burr superficial keratectomy</b> (after epithelial debridement) </p> <p>5.0 mm diamond ball burr to polish denuded corneal surface for 30 seconds</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sham diamond burr superficial keratectomy</b> (after epithelial debridement). </p> <p>Sham procedure performed without contact of corneal surface.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Epithelial debridement: loose epithelium removed using cellulose sponge.</p> <p>Tobramycin ointment (Tobrex; Alcon) and homatropine 4% cycloplegic eyedrops were applied followed by an eye patch overnight. Postoperatively, participants received a regimen of levofloxacin 0.5% (Cravit; Santen, Osaka, Japan)<br/> for 1 week and lubricating gel (Viscotears; Novartis, Basel,<br/> Switzerland) tapered over 3–4 months </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>One‐off procedure and topical treatment over 3‐4 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001861-bbs2-0010" title="YamadaM , MashimaY . Three‐step treatment of recurrent corneal erosion. Folia Ophthalmologica Japonica1998;49(10):839‐43. ">Yamada 1998</a> prophylaxis study </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prophylaxis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Japan</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>21‐71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>35%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Antibiotic</b> </p> <p>tetracycline ointment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> <p>hypertonic saline ointment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>6 months if no subjective symptoms, 3 months if no signs</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001861-bbs2-0010" title="YamadaM , MashimaY . Three‐step treatment of recurrent corneal erosion. Folia Ophthalmologica Japonica1998;49(10):839‐43. ">Yamada 1998</a> </p> <p>treatment study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Epithelial debridement</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Anterior stromal puncture</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Therapeutic contact lens</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="13"> <div class="table-footnote"> <p>NR: not reported</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Included studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/full#CD001861-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001861-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Therapeutic contact lens versus topical lubrication</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Resolution of symptoms after treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Recurrence after partial or complete resolution <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Therapeutic contact lens versus topical lubrication</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/references#CD001861-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001861-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Phototherapeutic keratectomy (PTK) versus alcohol delamination (ALD)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Resolution of symptoms after treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Recurrence after partial or complete resolution <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Pain score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Recurrence requiring further treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Phototherapeutic keratectomy (PTK) versus alcohol delamination (ALD)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/references#CD001861-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001861-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Diamond burr superficial keratectomy versus epithelial debridement</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Recurrence after partial or complete resolution <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Corneal haze <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Diamond burr superficial keratectomy versus epithelial debridement</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/references#CD001861-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001861-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Transepithelial verus subepithelial excimer laser ablation</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Recurrence of complete or partial resolution <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Transepithelial verus subepithelial excimer laser ablation</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/references#CD001861-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001861-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Excimer laser (after epithelial debridement) versus no excimer laser (after epithelial debridement)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Recurrence after partial or complete resolution <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Symptoms (pain score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Recurrences requiring further treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Excimer laser (after epithelial debridement) versus no excimer laser (after epithelial debridement)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/references#CD001861-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001861-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Topical lubrication versus no topical lubrication (prophylaxis)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Development of recurrent corneal erosions at 3 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Severe symptoms (confirmed macroform recurrent corneal erosion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Moderate symptoms (difficulty with daily activities/ sought further opinion) or severe symptoms </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Mild symptoms (non‐disabling), moderate or severe symptoms</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Development of recurrent corneal erosions at 3 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Severe symptoms (confirmed macroform recurrent corneal erosion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Topical lubrication versus no topical lubrication (prophylaxis)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001861.pub4/references#CD001861-tbl-0010">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD001861.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD001861-note-0002">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD001861-note-0004">فارسی</a> </li> <li class="section-language"> <a class="" href="ms#CD001861-note-0003">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD001861-note-0001">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD001861-note-0010">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001861\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001861\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001861\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001861\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001861\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001861\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001861\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001861\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001861\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001861\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001861\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001861\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001861\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001861\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001861\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001861\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001861\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001861\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=k5rEBE5b&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001861.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD001861.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD001861.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD001861.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001861.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740711483108"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD001861.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740711483111"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD001861.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d2686dc109377',t:'MTc0MDcxMTQ4My4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 